col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: European Centre for Disease Control and Prevention (ECDC)

501 Results       Page 1

  original article Journal Date Title Authors All Authors
1 [GO] Eurosurveillance 2024―May―17 Letter to the editor: Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic Xiangting Liu, Guangting Zeng
2 [GO] Eurosurveillance 2024―May―17 Authors’ response: Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic Wei Cai, Sophie Köndgen, Kristin Tolksdorf, Ralf Dürrwald, Barbara Biere, Walter Haas, et al. (+3)
3 [GO] Eurosurveillance 2024―May―10 Letter to the editor: Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
4 [GO] Eurosurveillance 2024―May―10 Author’s response: Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity Raphaëlle Klitting, Xavier de Lamballerie
5 [GO] Eurosurveillance 2024―Apr―12 Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024 Sarah K Nørgaard, Jens Nielsen, Anne Christine Nordholm, Lukas Richter, Alena Chalupka, Natalia Bustos Sierra, et al. (+46)
6 [GO] Eurosurveillance 2024―Mar―31 Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023 Wei Cai, Sophie Köndgen, Kristin Tolksdorf, Ralf Dürrwald, Ekkehard Schuler, Barbara Biere, et al. (+6)
7 [GO] Eurosurveillance 2024―Mar―31 COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022 Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, Lisa Domegan, Clara Mazagatos, Silke Buda, et al. (+36)
8 [GO] Eurosurveillance 2024―Mar―08 Projecting COVID-19 intensive care admissions for policy advice, the Netherlands, February 2020 to January 2021 Don Klinkenberg, Jantien Backer, Nicolette de Keizer, Jacco Wallinga
9 [GO] Eurosurveillance 2024―Mar―08 Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024 Anne J Huiberts, Christina E Hoeve, Brechje de Gier, Jeroen Cremer, Bas van der Veer, Hester E de Melker, et al. (+4)
10 [GO] Eurosurveillance 2024―Feb―23 Wastewater-based reproduction numbers and projections of COVID-19 cases in three areas in Japan, November 2021 to December 2022 Shogo Miyazawa, Ting Sam Wong, Genta Ito, Ryo Iwamoto, Kozo Watanabe, Michiel van Boven, et al. (+2)
11 [GO] Eurosurveillance 2024―Feb―23 Application of the screening method for estimating COVID-19 vaccine effectiveness using routine surveillance data: Germany’s experience during the COVID-19 pandemic, July 2021 to March 2023 Nita Perumal, Viktoria Schönfeld, Ole Wichmann
12 [GO] Eurosurveillance 2024―Feb―16 Bias in vaccine effectiveness studies of clinically severe outcomes that are measured with low specificity: the example of COVID-19-related hospitalisation Christian Holm Hansen
13 [GO] Eurosurveillance 2024―Jan―26 Letter to the editor: Added value of backward contact tracing for COVID-19 Graham Fraser, Gareth Hughes, Simon Packer, Obaghe Edeghere, Isabel Oliver
14 [GO] Eurosurveillance 2024―Jan―26 Authors’ response: Added value of backward contact tracing for COVID-19 Timo Louis Boelsums, Maaike Buskermolen
15 [GO] Eurosurveillance 2024―Jan―19 Time trends and modifiable factors of COVID-19 contact tracing coverage, Geneva, Switzerland, June 2020 to February 2022 Denis Mongin, Nils Bürgisser, Delphine Sophie Courvoisier
16 [GO] Eurosurveillance 2024―Jan―19 Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 Liliana Antunes, Clara Mazagatos, Iván Martínez-Baz, Verónica Gomez, Maria-Louise Borg, Goranka Petrović, et al. (+24)
17 [GO] Eurosurveillance 2024―Jan―12 Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023 Lara M Jeworowski, Barbara Mühlemann, Felix Walper, Marie L Schmidt, Jenny Jansen, Andi Krumbholz, et al. (+4)
18 [GO] Eurosurveillance 2024―Jan―05 Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023 Mario Fontán-Vela, Esther Kissling, Nathalie Nicolay, Toon Braeye, Izaak Van Evercooren, Christian Holm Hansen, et al. (+16)
19 [GO] Eurosurveillance 2024―Jan―05 Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023 C Henri van Werkhoven, Anne-Wil Valk, Bente Smagge, Hester E de Melker, Mirjam J Knol, Susan JM Hahné, et al. (+2)
20 [GO] Eurosurveillance 2023―Dec―15 Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022 Wieke Altorf-van der Kuil, Cornelia CH Wielders, Romy D Zwittink, Sabine C de Greeff, Dave A. Dongelmans, Ed J Kuijper, et al. (+2)
21 [GO] Eurosurveillance 2023―Dec―01 Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022 Anastasia Chatzilena, Catherine Hyams, Rob Challen, Robin Marlow, Jade King, David Adegbite, et al. (+6)
22 [GO] Eurosurveillance 2023―Nov―24 Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023 Bette Liu, Sandrine Stepien, Ketaki Sharma, Kristine Macartney
23 [GO] Eurosurveillance 2023―Nov―24 Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 Angela MC Rose, Nathalie Nicolay, Virginia Sandonis Martín, Clara Mazagatos, Goranka Petrović, F Annabel Niessen, et al. (+50)
24 [GO] Eurosurveillance 2023―Nov―24 Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022 Angela MC Rose, Nathalie Nicolay, Virginia Sandonis Martín, Clara Mazagatos, Goranka Petrović, Joaquin Baruch, et al. (+53)
25 [GO] Eurosurveillance 2023―Nov―17 Early detection of the emerging SARS-CoV-2 BA.2.86 lineage through integrated genomic surveillance of wastewater and COVID-19 cases in Sweden, weeks 31 to 38 2023 Carmen Espinosa-Gongora, Carlo Berg, Moa Rehn, Javier Edo Varg, Lena Dillner, Neus Latorre-Margalef, et al. (+3)
26 [GO] Eurosurveillance 2023―Nov―17 Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022 Cèlia Ventura-Gabarró, Vivian H Leung, Vera Vlahović-Palčevski, Anna Machowska, Dominique L Monnet, Liselotte Diaz Högberg
27 [GO] Eurosurveillance 2023―Nov―10 Investigation of an international water polo tournament in Czechia as a potential source for early introduction of the SARS-CoV-2 Omicron variant into Belgium, Switzerland and Germany, November 2021 Christoph Rudin, Nena Bollen, Samuel L Hong, Fanny Wegner, Lida Politi, Kassiani Mellou, et al. (+14)
28 [GO] Eurosurveillance 2023―Nov―03 PCR testing of traced contacts for SARS-CoV-2 in England, January to July 2021 Toby Nonnenmacher, Niharika Dandamudi, Matthias Erwin Futschik, Sarah A Tunkel, Raghavendran Kulasegaran-Shylini, Nick Germanacos, et al. (+7)
29 [GO] Eurosurveillance 2023―Oct―13 The value of manual backward contact tracing to control COVID-19 in practice, the Netherlands, February to March 2021: a pilot study Timo Louis Boelsums, Inge Anna Theresia van de Luitgaarden, Jane Whelan, Hanna Poell, Charlotte Maria Hoffman, Ewout Fanoy, et al. (+2)
30 [GO] Eurosurveillance 2023―Oct―13 Implementation of a broad public health approach to COVID-19 in Sweden, January 2020 to May 2022 Anders Tegnell, Anna Bessö, Britta Björkholm, Sara Byfors, Johan Carlson, Karin Tegmark Wisell
31 [GO] Eurosurveillance 2023―Oct―13 Epidemiology of common infectious diseases before and during the COVID-19 pandemic in Bavaria, Germany, 2016 to 2021: an analysis of routine surveillance data Sarah van de Berg, Tanja Charles, Achim Dörre, Katharina Katz, Stefanie Böhm
32 [GO] Eurosurveillance 2023―Oct―06 A comparison of COVID-19 incidence rates across six European countries in 2021 Michael Padget, Pauline Adam, Marina Dorfmuller, Clara Blondel, Ines Campos-Matos, Myriam Fayad, et al. (+9)
33 [GO] Eurosurveillance 2023―Sep―29 High attack rate in a large care home outbreak of SARS-CoV-2 BA.2.86, East of England, August 2023 Lucy Reeve, Elise Tessier, Amy Trindall, Nurin Iwani Binti Abdul Aziz, Nick Andrews, Matthias Futschik, et al. (+19)
34 [GO] Eurosurveillance 2023―Sep―22 Can variants, reinfection, symptoms and test types affect COVID-19 diagnostic performance? A large-scale retrospective study of AG-RDTs during circulation of Delta and Omicron variants, Czechia, December 2021 to February 2022 Tomáš Kliegr, Jiří Jarkovský, Helena Jiřincová, Jaroslav Kuchař, Tomáš Karel, David Chudán, et al. (+4)
35 [GO] Eurosurveillance 2023―Sep―22 Surveillance of SARS-CoV-2 infection based on self-administered swabs, Denmark, May to July 2022: evaluation of a pilot study Kamille Fogh, Tine Graakjær Larsen, Cyril Jean-Marie Martel, Frederik Trier Møller, Lasse Skafte Vestergaard, Ramona Trebbien, et al. (+2)
36 [GO] Eurosurveillance 2023―Sep―15 The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022 Catherine GA Pendrey, Janet Strachan, Heidi Peck, Ammar Aziz, Jean Moselen, Rob Moss, et al. (+4)
37 [GO] Eurosurveillance 2023―Sep―08 First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023 Morten Rasmussen, Frederik Trier Møller, Vithiagaran Gunalan, Sharmin Baig, Marc Bennedbæk, Lasse Engbo Christiansen, et al. (+26)
38 [GO] Eurosurveillance 2023―Sep―08 A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022 Tommy Nyberg, Peter Bager, Ingrid Bech Svalgaard, Dritan Bejko, Nick Bundle, Josie Evans, et al. (+14)
39 [GO] Eurosurveillance 2023―Sep―01 Reversed urban-rural gradient in COVID-19 seroprevalence and related factors in a nationally representative survey, Poland, 29 March to 14 May 2021 Michał Czerwiński, Małgorzata Stępień, Grzegorz Juszczyk, Małgorzata Sadkowska-Todys, Adam Zieliński, Jakub Rutkowski, Magdalena Rosińska
40 [GO] Eurosurveillance 2023―Aug―18 A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022 Robert Whittaker, Salla Toikkanen, Katharine Dean, Trude Marie Lyngstad, Eirik Alnes Buanes, Hilde Kløvstad, et al. (+2)
41 [GO] Eurosurveillance 2023―Aug―11 Revisiting the personal protective equipment components of transmission-based precautions for the prevention of COVID-19 and other respiratory virus infections in healthcare Diamantis Plachouras, Oliver Kacelnik, Jesús Rodríguez-Baño, Gabriel Birgand, Michael A Borg, Brian Kristensen, et al. (+8)
42 [GO] Eurosurveillance 2023―Aug―11 Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 Massimo Fabiani, Alberto Mateo-Urdiales, Chiara Sacco, Maria Cristina Rota, Emmanouil Alexandros Fotakis, Daniele Petrone, et al. (+9)
43 [GO] Eurosurveillance 2023―Jul―21 The COVID-19 pandemic in Greenland, epidemic features and impact of early strict measures, March 2020 to June 2022 Paneeraq Noahsen, Louise Lohmann Faber, Silvia Isidor, Jannik Fonager, Morten Rasmussen, Henrik L Hansen
44 [GO] Eurosurveillance 2023―Jul―17 SARS-CoV-2 in lions, gorillas and zookeepers in the Rotterdam Zoo, the Netherlands, a One Health investigation, November 2021 Florien Dusseldorp, Linda G.R. Bruins-van-Sonsbeek, Maaike Buskermolen, Henk Niphuis, Mariëlle Dirven, Jane Whelan, et al. (+5)
45 [GO] Eurosurveillance 2023―Jul―14 Influenza transmission during COVID-19 measures downscaling in Greece, August 2022: evidence for the need of continuous integrated surveillance of respiratory viruses Kassiani Mellou, Kyriaki Tryfinopoulou, Mary Emmanouil, Kassiani Gkolfinopoulou, Spyros Sapounas, Maria Evangelidou, et al. (+6)
46 [GO] Eurosurveillance 2023―Jun―30 Enhanced surveillance of hospitalised COVID-19 patients in Europe: I-MOVE-COVID-19 surveillance network, February 2020 to December 2021 Heather Mutch, Johanna J Young, Fatima Sadiq, Angela MC Rose, Josie MM Evans
47 [GO] Eurosurveillance 2023―Jun―30 COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022 Toon Braeye, Joris A F van Loenhout, Ruben Brondeel, Veerle Stouten, Pierre Hubin, Matthieu Billuart, et al. (+5)
48 [GO] Eurosurveillance 2023―Jun―23 Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021 Tom Woudenberg, Laurie Pinaud, Laura Garcia, Laura Tondeur, Stéphane Pelleau, Alix De Thoisy, et al. (+15)
49 [GO] Eurosurveillance 2023―Jun―23 Patterns of SARS-CoV-2 circulation revealed by a nationwide sewage surveillance programme, the Netherlands, August 2020 to February 2022 Michiel van Boven, Wouter A Hetebrij, Arno Swart, Erwin Nagelkerke, Rudolf FHJ van der Beek, Sjors Stouten, et al. (+7)
50 [GO] Eurosurveillance 2023―Jun―16 Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021 Helmar C Lehmann, Doris Oberle, Brigitte Keller-Stanislawski, Thorsten Rieck, Renz Streit
51 [GO] Eurosurveillance 2023―Jun―16 Innovative platforms for data aggregation, linkage and analysis in the context of pandemic and epidemic intelligence Beth Blauer, John Brownstein, Lauren Gardner, Moritz UG Kraemer, Zoila Leiva Rioja, Edouard Mathieu, et al. (+2)
52 [GO] Eurosurveillance 2023―Jun―05 Emergence, spread and characterisation of the SARS-CoV-2 variant B.1.640 circulating in France, October 2021 to February 2022 Gwenola Picard, Lucie Fournier, Anna Maisa, Claire Grolhier, Souhaila Chent, Caroline Huchet-Kervalla, et al. (+5)
53 [GO] Eurosurveillance 2023―Jun―03 Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023 Thi Ngoc Anh Hoang, Ha-Linh Quach, Van Ngoc Hoang, Van Thien Tran, Quang Thai Pham, Florian Vogt
54 [GO] Eurosurveillance 2023―May―26 Comprehensive surveillance of acute respiratory infections during the COVID-19 pandemic: a methodological approach using sentinel networks, Castilla y León, Spain, January 2020 to May 2022 Tomás Vega-Alonso, Jose Eugenio Lozano-Alonso, Ana Ordax-Díez
55 [GO] Eurosurveillance 2023―May―26 Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study Nana Owusu-Boaitey, Timothy W Russell, Gideon Meyerowitz-Katz, Andrew T Levin, Daniel Herrera-Esposito
56 [GO] Eurosurveillance 2023―May―12 Serosurveillance of SARS-CoV-2 in Welsh Blood Donors: Establishment of the surveillance system and results up to November 2022 Sophie Harker, Siân Elizabeth James, James Murphy, Ben Davies, Catherine Moore, Brian P Tennant, et al. (+2)
57 [GO] Eurosurveillance 2023―May―05 Tick-borne encephalitis epidemiology and surveillance in Poland, and comparison with selected European countries before and during the COVID-19 pandemic, 2008 to 2020 Iwona Paradowska-Stankiewicz, Katarzyna Pancer, Anna Poznańska, Martyna Hordowicz, Maria Skibicka, Marek Słowiński, et al. (+2)
58 [GO] Eurosurveillance 2023―May―05 SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022 Olivier Supplisson, Tiffany Charmet, Simon Galmiche, Laura Schaeffer, Olivia Chény, Anne Lévy, et al. (+5)
59 [GO] Eurosurveillance 2023―May―05 The role of children in transmission of SARS-CoV-2 variants of concern within households: an updated systematic review and meta-analysis, as at 30 June 2022 Yanshan Zhu, Yao Xia, Janessa Pickering, Asha C Bowen, Kirsty R Short
60 [GO] Eurosurveillance 2023―Apr―28 Effects of non-compulsory and mandatory COVID-19 interventions on travel distance and time away from home, Norway, 2021 Meghana Kamineni, Kenth Engø-Monsen, Jørgen E Midtbø, Frode Forland, Birgitte Freiesleben de Blasio, Arnoldo Frigessi, Solveig Engebretsen
61 [GO] Eurosurveillance 2023―Apr―24 Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany Andreas Puyskens, Fatimanur Bayram, Akin Sesver, Janine Michel, Eva Krause, Daniel Bourquain, et al. (+7)
62 [GO] Eurosurveillance 2023―Apr―22 COVID-19 outbreaks among crew on commercial ships at the Port of Rotterdam, the Netherlands, 2020 to 2021 Edward Gebuis, Bruno Vieyra, Rob Slegtenhorst, Saskia Wiegmans, Bas van Dijk, Thijs Veenstra, et al. (+7)
63 [GO] Eurosurveillance 2023―Apr―22 Cryptic SARS-CoV-2 lineage identified on two mink farms as a possible result of long-term undetected circulation in an unknown animal reservoir, Poland, November 2022 to January 2023 Katarzyna Domańska-Blicharz, Bas B Oude Munnink, Anna Orłowska, Marcin Smreczak, Justyna Opolska, Anna Lisowska, et al. (+7)
64 [GO] Eurosurveillance 2023―Apr―14 A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022 Nicolas Guibert, Kylian Trepat, Bruno Pozzetto, Laurence Josset, Jean-Baptiste Fassier, Omran Allatif, et al. (+5)
65 [GO] Eurosurveillance 2023―Apr―14 Limited transmission of SARS-CoV-2 in schools in Ireland during the 2020-2021 school year Ciara Kelly, Philippa White, Elizabeth Kennedy, Dearbhail O’Flynn, Aoife Colgan, Mary Ward, et al. (+11)
66 [GO] Eurosurveillance 2023―Mar―31 A methodological approach to intra-action reviews - application and adaptation of existing global guidance during the COVID-19 pandemic response in Ireland, 2021 Eoghan O’Connor, Mary O’Riordan, Mary C. Morrissey, Niamh Dever, Cliodhna O’Mahony, Shem Romanowski, Máirín Boland
67 [GO] Eurosurveillance 2023―Mar―31 At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study Julia Wigren Byström, Linnea Vikström, Ebba Rosendal, Remigius Gröning, Yong-Dae Gwon, Emma Nilsson, et al. (+16)
68 [GO] Eurosurveillance 2023―Mar―31 Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022 Massimo Vicentini, Francesco Venturelli, Pamela Mancuso, Eufemia Bisaccia, Alessandro Zerbini, Marco Massari, et al. (+5)
69 [GO] Eurosurveillance 2023―Mar―24 A new method for near real-time, nationwide surveillance of nosocomial COVID-19 in Norway: providing data at all levels of the healthcare system, March 2020 to March 2022 Håvard Skagseth, Silje Bakken Jørgensen, Jacqui Reilly, Oliver Kacelnik
70 [GO] Eurosurveillance 2023―Mar―17 Using an influenza surveillance system to estimate the number of SARS-CoV-2 infections in Beijing, China, weeks 2 to 6 2023 Li Zhang, Yi Zhang, Wei Duan, Shuangsheng Wu, Ying Sun, Chunna Ma, et al. (+3)
71 [GO] Eurosurveillance 2023―Mar―03 Letter to the Editor: Knowledge gap in assessing the risk of a human pandemic via mammals’ infection with highly pathogenic avian influenza A(H5N1) Hiroshi Nishiura, Taishi Kayano, Katsuma Hayashi, Tetsuro Kobayashi, Yuta Okada
72 [GO] Eurosurveillance 2023―Feb―24 Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022 Massimo Fabiani, Alberto Mateo-Urdiales, Chiara Sacco, Emmanouil Alexandros Fotakis, Maria Cristina Rota, Daniele Petrone, et al. (+11)
73 [GO] Eurosurveillance 2023―Feb―24 SARS-CoV-2 molecular epidemiology in Slovenia, January to September 2021 Sandra Janezic, Aleksander Mahnic, Urška Kuhar, Jernej Kovač, Barbara Jenko Bizjan, Tom Koritnik, et al. (+8)
74 [GO] Eurosurveillance 2023―Feb―17 Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022 Stijn P Andeweg, Brechje de Gier, Harry Vennema, Ivo van Walle, Noortje van Maarseveen, Nina E Kusters, et al. (+5)
75 [GO] Eurosurveillance 2023―Feb―17 Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022 Anne J Huiberts, Brechje de Gier, Christina E Hoeve, Hester E de Melker, Susan JM Hahné, Gerco den Hartog, et al. (+3)
76 [GO] Eurosurveillance 2023―Feb―03 Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022 Iván Martínez-Baz, Camino Trobajo-Sanmartín, Ana Miqueleiz, Itziar Casado, Ana Navascués, Cristina Burgui, et al. (+3)
77 [GO] Eurosurveillance 2023―Jan―27 Low SARS-CoV-2 Cq values in healthcare workers with symptomatic COVID-19 infections, regardless of symptom severity, The Netherlands, January to August 2022 Carsten van Rossum, Corianne Meijer, Ingrid JM van Weerdenburg, Edmée C Bowles, Chantal P Rovers, Jaap ten Oever, et al. (+4)
78 [GO] Eurosurveillance 2023―Jan―27 Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, et al. (+22)
79 [GO] Eurosurveillance 2023―Jan―27 Response to Letter to the Editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies Catharina E van Ewijk, Susan JM Hahné, Mirjam J Knol
80 [GO] Eurosurveillance 2023―Jan―27 Association of SARS-CoV-2 viral load distributions with individual demographics and suspected variant type: results from the Liverpool community testing pilot, England, 6 November 2020 to 8 September 2021 David M Hughes, Christopher P Cheyne, Matthew Ashton, Emer Coffey, Alex Crozier, Malcolm G Semple, et al. (+2)
81 [GO] Eurosurveillance 2023―Jan―20 COVID-19 mortality attenuated during widespread Omicron transmission, Denmark, 2020 to 2022 Nikolaj U Friis, Tomas Martin-Bertelsen, Rasmus K Pedersen, Jens Nielsen, Tyra G Krause, Viggo Andreasen, Lasse S Vestergaard
82 [GO] Eurosurveillance 2023―Jan―20 Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study Ruby SM Tsang, Mark Joy, Rachel Byford, Chris Robertson, Sneha N Anand, William Hinton, et al. (+15)
83 [GO] Eurosurveillance 2023―Jan―13 Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022 Federica Novazzi, Emanuela Giombini, Martina Rueca, Andreina Baj, Lavinia Fabeni, Angelo Genoni, et al. (+13)
84 [GO] Eurosurveillance 2023―Jan―06 Detecting early signals of COVID-19 outbreaks in 2020 in small areas by monitoring healthcare utilisation databases: first lessons learned from the Italian Alert_CoV project Ivan Merlo, Mariano Crea, Paolo Berta, Francesca Ieva, Flavia Carle, Federico Rea, et al. (+14)
85 [GO] Eurosurveillance 2022―Dec―09 The World Health Organization’s public health intelligence activities during the COVID-19 pandemic response, December 2019 to December 2021 Eri Togami, Bridget Griffith, Mostafa Mahran, Ingrid H Nezu, Bernadette B Mirembe, Kaja Kaasik-Aaslav, et al. (+33)
86 [GO] Eurosurveillance 2022―Dec―02 A framework for measuring timeliness in the outbreak response path: lessons learned from the Middle East respiratory syndrome (MERS) epidemic, September 2012 to January 2019 Carolina dos S Ribeiro, Martine van Roode, Elmoubasher Farag, Mohamed Nour, Aya Moustafa, Minahil Ahmed, et al. (+3)
87 [GO] Eurosurveillance 2022―Nov―18 Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 Pete Kinross, Carlo Gagliotti, Hanna Merk, Diamantis Plachouras, Dominique L Monnet, Liselotte Diaz Högberg
88 [GO] Eurosurveillance 2022―Nov―11 COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021 Catharina E van Ewijk, Marjolein N Kooijman, Ewout Fanoy, Stijn FH Raven, Marit Middeldorp, Anita Shah, et al. (+4)
89 [GO] Eurosurveillance 2022―Nov―11 Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 Paola Stefanelli, Filippo Trentini, Daniele Petrone, Alessia Mammone, Luigina Ambrosio, Mattia Manica, et al. (+17)
90 [GO] Eurosurveillance 2022―Nov―04 A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021 Kylie E C Ainslie, Jantien A Backer, Pieter T de Boer, Albert Jan van Hoek, Don Klinkenberg, Hester Korthals Altes, et al. (+4)
91 [GO] Eurosurveillance 2022―Oct―28 Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021 Torsten Houwaart, Samir Belhaj, Emran Tawalbeh, Dirk Nagels, Yara Fröhlich, Patrick Finzer, et al. (+40)
92 [GO] Eurosurveillance 2022―Oct―22 Public health measures during the COVID-19 pandemic through the lens of community organisations and networks in the Netherlands (2020-2021): five lessons for pandemic decision-making Carla Kolner, Wieke van der Borg, Jet Sanders, Jolanda Keijsers, Maysa Joosten, Marijn de Bruin
93 [GO] Eurosurveillance 2022―Oct―22 External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021 Ramona Mögling, Francesca Colavita, Johan Reimerink, Angeliki Melidou, Katrin Leitmeyer, Maria Keramarou, et al. (+11)
94 [GO] Eurosurveillance 2022―Oct―14 Non-pharmaceutical interventions in response to the COVID-19 pandemic in 30 European countries: the ECDC-JRC Response Measures Database Lorenzo Lionello, Debora Stranges, Tommi Karki, Emma Wiltshire, Chiara Proietti, Alessandro Annunziato, et al. (+2)
95 [GO] Eurosurveillance 2022―Oct―07 SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021 Tal Patalon, Shay Ben Moshe, Asaf Peretz, Ami Neuberger, Licita Schreiber, Rachel Lazar, et al. (+4)
96 [GO] Eurosurveillance 2022―Oct―07 Exploring behavioural factors influencing COVID-19-specific infection prevention and control measures in Finland: a mixed-methods study, December 2020 to March 2021 Anna-Leena Lohiniva, Saija Toura, Dinah Arifulla, Jukka Ollgren, Outi Lyytikäinen
97 [GO] Eurosurveillance 2022―Sep―30 Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021 Hannes Winner, Janine Kimpel, Florian Krammer, Dorothee von Laer, Jörg Paetzold
98 [GO] Eurosurveillance 2022―Sep―30 Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022 Noam Barda, Michal Canetti, Mayan Gilboa, Victoria Indenboim, Keren Asraf, Yael Weiss-Ottolenghi, et al. (+9)
99 [GO] Eurosurveillance 2022―Sep―16 COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022 Irina Kislaya, Ausenda Machado, Sarah Magalhães, Ana Paula Rodrigues, Rafael Franco, Pedro Pinto Leite, et al. (+2)
100 [GO] Eurosurveillance 2022―Sep―16 Seroconversion rate and socio-economic and ethnic risk factors for SARS-CoV-2 infection in children in a population-based cohort, Germany, June 2020 to February 2021 Folke Brinkmann, Hans H Diebner, Chantal Matenar, Anne Schlegtendal, Lynn Eitner, Nina Timmesfeld, et al. (+2)
101 [GO] Eurosurveillance 2022―Sep―02 Age-specific associations between underlying health conditions and hospitalisation, death and in-hospital death among confirmed COVID-19 cases: a multi-country study based on surveillance data, June to December 2020 Tjede Funk, Francesco Innocenti, Joana Gomes Dias, Lina Nerlander, Tanya Melillo, Charmaine Gauci, et al. (+20)
102 [GO] Eurosurveillance 2022―Aug―26 Epidemiological profile of COVID-19 in the French overseas department Mayotte, 2020 to 2021 Marion Subiros, Charlotte Robert De Latour, Fanny Parenton, Ibtissame Soulaimana, Youssouf Hassani, Renaud Blondé, et al. (+18)
103 [GO] Eurosurveillance 2022―Aug―20 Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022 Jesús Castilla, Óscar Lecea, Carmen Martín Salas, Delia Quílez, Ana Miqueleiz, Camino Trobajo-Sanmartín, et al. (+7)
104 [GO] Eurosurveillance 2022―Aug―20 Role of population and test characteristics in antigen-based SARS-CoV-2 diagnosis, Czechia, August to November 2021 Tomáš Kliegr, Jiří Jarkovský, Helena Jiřincová, Jaroslav Kuchař, Tomáš Karel, Ruth Tachezy
105 [GO] Eurosurveillance 2022―Aug―12 SARS-CoV-2 infection in households with and without young children: Nationwide cohort study, Denmark, 27 February 2020 to 26 February 2021 Anders Husby, Giulia Corn, Tyra Grove Krause
106 [GO] Eurosurveillance 2022―Aug―05 Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022 Rebecca Amati, Anja Frei, Marco Kaufmann, Serena Sabatini, Céline Pellaton, Jan Fehr, et al. (+2)
107 [GO] Eurosurveillance 2022―Jul―30 COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022 Limor Kliker, Neta Zuckerman, Nofar Atari, Noam Barda, Mayan Gilboa, Ital Nemet, et al. (+8)
108 [GO] Eurosurveillance 2022―Jul―30 Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022 Alexis Sentís, Irina Kislaya, Nathalie Nicolay, Hinta Meijerink, Jostein Starrfelt, Iván Martínez-Baz, et al. (+9)
109 [GO] Eurosurveillance 2022―Jul―22 Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond Daniel Simões, Soudeh Ehsani, Maja Stanojevic, Natalia Shubladze, Gulmira Kalmambetova, Roger Paredes, et al. (+10)
110 [GO] Eurosurveillance 2022―Jul―01 Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned Jayshree Bagaria, Tessa Jansen, Diogo FP Marques, Mariette Hooiveld, Jim McMenamin, Simon de Lusignan, et al. (+11)
111 [GO] Eurosurveillance 2022―Jun―24 Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020 Soraya Matczak, Corinne Levy, Camille Fortas, Jérémie F Cohen, Stéphane Béchet, Fatima Aït El Belghiti, et al. (+10)
112 [GO] Eurosurveillance 2022―Jun―10 Impact of stringent non-pharmaceutical interventions applied during the second and third COVID-19 epidemic waves in Portugal, 9 November 2020 to 10 February 2021: an ecological study Ana Rita Torres, Ana Paula Rodrigues, Mafalda Sousa-Uva, Irina Kislaya, Susana Silva, Liliana Antunes, et al. (+2)
113 [GO] Eurosurveillance 2022―Jun―03 SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022 Claudia Sievers, Benedikt Zacher, Alexander Ullrich, Matthew Huska, Stephan Fuchs, Silke Buda, et al. (+4)
114 [GO] Eurosurveillance 2022―May―30 Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021 Esther Kissling, Mariëtte Hooiveld, Iván Martínez-Baz, Clara Mazagatos, Naoma William, Ana-Maria Vilcu, et al. (+40)
115 [GO] Eurosurveillance 2022―May―30 Investigation of a COVID-19 outbreak on the Charles de Gaulle aircraft carrier, March to April 2020: a retrospective cohort study Franck de Laval, Hervé Chaudet, Olivier Gorgé, Joffrey Marchi, Constance Lacrosse, Aissata Dia, et al. (+14)
116 [GO] Eurosurveillance 2022―May―30 Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022 Liesbet Van Heirstraeten, Esra Ekinci, Mathias Smet, Matilda Berkell, Laura Willen, Jasmine Coppens, et al. (+11)
117 [GO] Eurosurveillance 2022―May―20 mRNA vaccine effectiveness against hospitalisation due to severe acute respiratory infection (SARI) COVID-19 during Omicron variant predominance estimated from real-world surveillance data, Slovenia, February to March 2022 Marta Grgič Vitek, Irena Klavs, Veronika Učakar, Marjana Vrh, Maja Mrzel, Mojca Serdt, Mario Fafangel
118 [GO] Eurosurveillance 2022―May―20 Hospitalised patients with breakthrough COVID-19 following vaccination during two distinct waves in Israel, January to August 2021: a multicentre comparative cohort study Tal Brosh-Nissimov, Yasmin Maor, Meital Elbaz, Shelly Lipman-Arens, Yonit Wiener-Well, Khetam Hussein, et al. (+11)
119 [GO] Eurosurveillance 2022―May―20 Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020 Gavin Dabrera, Hester Allen, Asad Zaidi, Joe Flannagan, Katherine Twohig, Simon Thelwall, et al. (+15)
120 [GO] Eurosurveillance 2022―May―20 Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022 Chiara Sacco, Daniele Petrone, Martina Del Manso, Alberto Mateo-Urdiales, Massimo Fabiani, Marco Bressi, et al. (+4)
121 [GO] Eurosurveillance 2022―May―20 The WHO Hub for Pandemic and Epidemic Intelligence; supporting better preparedness for future health emergencies Oliver Morgan, Richard Pebody
122 [GO] Eurosurveillance 2022―May―13 Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021 Patrick M Meyer Sauteur, Michael L Beeton, Søren A Uldum, Nathalie Bossuyt, Melissa Vermeulen, Katherine Loens, et al. (+9)
123 [GO] Eurosurveillance 2022―May―13 Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021 David García-García, Rafael Herranz-Hernández, Ayelén Rojas-Benedicto, Inmaculada León-Gómez, Amparo Larrauri, Marina Peñuelas, et al. (+3)
124 [GO] Eurosurveillance 2022―May―11 Behavioural insights and the evolving COVID-19 pandemic Marijn de Bruin, Jonathan E Suk, Marianna Baggio, Sarah Earnshaw Blomquist, María Falcon, Maria João Forjaz, et al. (+6)
125 [GO] Eurosurveillance 2022―May―11 COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022 Jonas Björk, Carl Bonander, Mahnaz Moghaddassi, Magnus Rasmussen, Ulf Malmqvist, Malin Inghammar, Fredrik Kahn
126 [GO] Eurosurveillance 2022―May―11 SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022 Samuel MS Cheng, Chris Ka Pun Mok, Karl CK Chan, Susanna S Ng, Bosco HS Lam, Leo LH Luk, et al. (+9)
127 [GO] Eurosurveillance 2022―Apr―29 Public health considerations for transitioning beyond the acute phase of the COVID-19 pandemic in the EU/EEA Jonathan E Suk, Anastasia Pharris, Julien Beauté, Edoardo Colzani, Howard Needham, John Kinsman, et al. (+11)
128 [GO] Eurosurveillance 2022―Apr―29 Social conformism and confidence in systems as additional psychological antecedents of vaccination: a survey to explain intention for COVID-19 vaccination among healthcare and welfare sector workers, France, December 2020 to February 2021 Simi Moirangthem, Cyril Olivier, Amandine Gagneux-Brunon, Gérard Péllissier, Dominique Abiteboul, Isabelle Bonmarin, et al. (+3)
129 [GO] Eurosurveillance 2022―Apr―22 Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022 Milena Suarez Castillo, Hamid Khaoua, Noémie Courtejoie
130 [GO] Eurosurveillance 2022―Apr―22 The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems Aharona Glatman-Freedman, Lea Gur-Arie, Hanna Sefty, Zalman Kaufman, Michal Bromberg, Rita Dichtiar, et al. (+9)
131 [GO] Eurosurveillance 2022―Apr―22 Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022 Erika Lindh, Teemu Smura, Soile Blomqvist, Kirsi Liitsola, Hanna Vauhkonen, Laura Savolainen, et al. (+8)
132 [GO] Eurosurveillance 2022―Apr―15 Transmission dynamics of COVID-19 in household and community settings in the United Kingdom, January to March 2020 Jamie Lopez Bernal, Nikolaos Panagiotopoulos, Chloe Byers, Tatiana Garcia Vilaplana, Nicki Boddington, Xu-Sheng Zhang, et al. (+19)
133 [GO] Eurosurveillance 2022―Apr―15 Innovations in public health surveillance: updates from a forum convened by the WHO Hub for Pandemic and Epidemic Intelligence, 2 and 3 February 2022
134 [GO] Eurosurveillance 2022―Apr―01 Risk factors associated with an outbreak of COVID-19 in a meat processing plant in southern Germany, April to June 2020 Iris Finci, Remo Siebenbaum, Josephin Richtzenhain, Angelika Edwards, Carina Rau, Jonas Ehrhardt, et al. (+3)
135 [GO] Eurosurveillance 2022―Apr―01 Immediate side effects of Comirnaty COVID-19 vaccine: A nationwide survey of vaccinated people in Israel, December 2020 to March 2021 Shirley Shapiro Ben David, Sharon Baruch Gez, Daniella Rahamim-Cohen, Na’ama Shamir-Stein, Uri Lerner, Anat Ekka Zohar
136 [GO] Eurosurveillance 2022―Apr―01 Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21 Erik Eik Anda, Tonje Braaten, Kristin Benjaminsen Borch, Therese Haugdahl Nøst, Sairah L F Chen, Marko Lukic, et al. (+8)
137 [GO] Eurosurveillance 2022―Apr―01 Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022 Jonathan Bastard, Benjamin Taisne, Julie Figoni, Alexandra Mailles, Julien Durand, Myriam Fayad, et al. (+5)
138 [GO] Eurosurveillance 2022―Apr―01 Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 - vigilance needed Jing Huang, Guangting Zeng
139 [GO] Eurosurveillance 2022―Mar―25 Set back on the way to meet SDG targets: progress in tackling tuberculosis reversed by the pandemic
140 [GO] Eurosurveillance 2022―Mar―18 SARS-CoV-2 infection among educational staff in Berlin, Germany, June to December 2020 Sophia Kindzierski, Welmoed van Loon, Stefanie Theuring, Franziska Hommes, Eberhard Thombansen, Malik Böttcher, et al. (+9)
141 [GO] Eurosurveillance 2022―Mar―18 Surveillance and return to work of healthcare workers following SARS-CoV-2 Omicron variant infection, Sheffield, England, 17 January to 7 February 2022 Mohammed Raza, Prosenjit Giri, Subhashis Basu
142 [GO] Eurosurveillance 2022―Mar―18 Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021 Paula B Blomquist, Jessica Bridgen, Neil Bray, Anne Marie O’Connell, Daniel West, Natalie Groves, et al. (+20)
143 [GO] Eurosurveillance 2022―Mar―11 Estimating the effect of mobility on SARS-CoV-2 transmission during the first and second wave of the COVID-19 epidemic, Switzerland, March to December 2020 Adrian Lison, Joel Persson, Nicolas Banholzer, Stefan Feuerriegel
144 [GO] Eurosurveillance 2022―Mar―11 Two years of COVID-19: many lessons, but will we learn? David L. Heymann, Helena Legido-Quigley
145 [GO] Eurosurveillance 2022―Mar―11 Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021 Min Kang, Hualei Xin, Jun Yuan, Sheikh Taslim Ali, Zimian Liang, Jiayi Zhang, et al. (+7)
146 [GO] Eurosurveillance 2022―Mar―11 Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022 Jannik Fonager, Marc Bennedbæk, Peter Bager, Jan Wohlfahrt, Kirsten Maren Ellegaard, Anna Cäcilia Ingham, et al. (+29)
147 [GO] Eurosurveillance 2022―Mar―11 Inferring transmission fitness advantage of SARS-CoV-2 variants of concern from wastewater samples using digital PCR, Switzerland, December 2020 through March 2021 Lea Caduff, David Dreifuss, Tobias Schindler, Alexander J Devaux, Pravin Ganesanandamoorthy, Anina Kull, et al. (+6)
148 [GO] Eurosurveillance 2022―Mar―04 Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022 Fredrik Kahn, Carl Bonander, Mahnaz Moghaddassi, Magnus Rasmussen, Ulf Malmqvist, Malin Inghammar, Jonas Björk
149 [GO] Eurosurveillance 2022―Mar―04 Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020 Sereina Annik Herzog, Jessie De Bie, Steven Abrams, Ine Wouters, Esra Ekinci, Lisbeth Patteet, et al. (+6)
150 [GO] Eurosurveillance 2022―Feb―25 From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020 Janko van Beek, Zsofia Igloi, Timo Boelsums, Ewout Fanoy, Hannelore Gotz, Richard Molenkamp, et al. (+5)
151 [GO] Eurosurveillance 2022―Feb―18 Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021 Gaetano Marrone, Nathalie Nicolay, Nick Bundle, Tommi Karki, Gianfranco Spiteri, Heleene Suija, et al. (+10)
152 [GO] Eurosurveillance 2022―Feb―18 COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020 Geert Molenberghs, Christel Faes, Johan Verbeeck, Patrick Deboosere, Steven Abrams, Lander Willem, et al. (+11)
153 [GO] Eurosurveillance 2022―Feb―18 SARS-CoV-2 testing in patients with low COVID-19 suspicion at admission to a tertiary care hospital, Stockholm, Sweden, March to September 2020 Ana Requena-Méndez, Aikaterini Mougkou, Pontus Hedberg, Suzanne D van der Werff, Hideyuki Tanushi, Olof Hertting, et al. (+3)
154 [GO] Eurosurveillance 2022―Feb―11 Early chains of transmission of COVID-19 in France, January to March 2020 Juliette Paireau, Alexandra Mailles, Catherine Eisenhauer, Franck de Laval, François Delon, Paolo Bosetti, et al. (+3)
155 [GO] Eurosurveillance 2022―Feb―11 Investigation of outbreak cases infected with the SARS-CoV-2 B.1.640 variant in a fully vaccinated elderly population, Normandy, France, November to December 2021 Brice Mastrovito, Chloé Naimi, Leslie Kouam, Xavier Naudot, Lucie Fournier, Guillaume Spaccaferri, et al. (+8)
156 [GO] Eurosurveillance 2022―Feb―11 Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021 Jantien A Backer, Dirk Eggink, Stijn P Andeweg, Irene K Veldhuijzen, Noortje van Maarseveen, Klaas Vermaas, et al. (+5)
157 [GO] Eurosurveillance 2022―Feb―11 Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 Samuel Alizon, Christian Selinger, Mircea T Sofonea, Stéphanie Haim-Boukobza, Jean-Marc Giannoli, Laetitia Ninove, et al. (+22)
158 [GO] Eurosurveillance 2022―Feb―11 Nationwide study on SARS-CoV-2 transmission within households from lockdown to reopening, Denmark, 27 February 2020 to 1 August 2020 Frederik Plesner Lyngse, Carsten Kirkeby, Tariq Halasa, Viggo Andreasen, Robert Leo Skov, Frederik Trier Møller, et al. (+2)
159 [GO] Eurosurveillance 2022―Feb―04 Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 Paola Stefanelli, Filippo Trentini, Giorgio Guzzetta, Valentina Marziano, Alessia Mammone, Monica Sane Schepisi, et al. (+9)
160 [GO] Eurosurveillance 2022―Feb―04 Transmission of SARS-CoV-2 by children: a rapid review, 30 December 2019 to 10 August 2020 Barbara Clyne, Karen Jordan, Susan Ahern, Kieran A Walsh, Paula Byrne, Paul G Carty, et al. (+6)
161 [GO] Eurosurveillance 2022―Jan―28 Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022 Lamprini Veneti, Håkon Bøås, Anja Bråthen Kristoffersen, Jeanette Stålcrantz, Karoline Bragstad, Olav Hungnes, et al. (+10)
162 [GO] Eurosurveillance 2022―Jan―28 Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022 Dirk Eggink, Stijn P Andeweg, Harry Vennema, Noortje van Maarseveen, Klaas Vermaas, Boris Vlaemynck, et al. (+5)
163 [GO] Eurosurveillance 2022―Jan―28 Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020 Scott JC Pallett, Rachael Jones, Ahmed Abdulaal, Mitchell A Pallett, Michael Rayment, Aatish Patel, et al. (+12)
164 [GO] Eurosurveillance 2022―Jan―21 Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021 Patrick WG Mallon, Mary Horgan, Conor G McAloon, Peter D Lunn, Julian Little, Andrew Beck, et al. (+5)
165 [GO] Eurosurveillance 2022―Jan―14 Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021 Shirley LL Kwok, Samuel MS Cheng, Jennifer NS Leung, Kathy Leung, Cheuk-Kwong Lee, JS Malik Peiris, Joseph T Wu
166 [GO] Eurosurveillance 2022―Jan―07 Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19 Georg Marcus Fröhlich, Marlieke E. A. De Kraker, Mohamed Abbas, Olivia Keiser, Amaury Thiabaud, Maroussia Roelens, et al. (+15)
167 [GO] Eurosurveillance 2022―Jan―07 Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021 Georgina Ireland, Heather Whitaker, Shamez N Ladhani, Frances Baawuah, Sathyvani Subbarao, Ezra Linley, et al. (+8)
168 [GO] Eurosurveillance 2022―Jan―07 Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22 Paolo Bosetti, Cécile Tran Kiem, Alessio Andronico, Juliette Paireau, Daniel Levy-Bruhl, Lise Alter, et al. (+2)
169 [GO] Eurosurveillance 2022―Jan―07 Unexposed populations and potential COVID-19 hospitalisations and deaths in European countries as per data up to 21 November 2021 Lloyd A C Chapman, Rosanna C Barnard, Timothy W Russell, Sam Abbott, Kevin van Zandvoort, Nicholas G Davies, Adam J Kucharski
170 [GO] Eurosurveillance 2022―Jan―07 Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021 Marta Grgič Vitek, Irena Klavs, Veronika Učakar, Mojca Serdt, Maja Mrzel, Marjana Vrh, Mario Fafangel
171 [GO] Eurosurveillance 2022―Jan―07 Letter to the editor: Time to consider unusual or severe headache and fatigue as indicator symptoms for COVID-19 testing? Alma Tostmann
172 [GO] Eurosurveillance 2022―Jan―07 A review of COVID-19 transmission dynamics and clinical outcomes on cruise ships worldwide, January to October 2020 Kathryn S Willebrand, Lauren Pischel, Amyn A Malik, Samuel M Jenness, Saad B Omer
173 [GO] Eurosurveillance 2021―Dec―17 Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia Marco Del Riccio, Bruno Lina, Saverio Caini, Lisa Staadegaard, Sytske Wiegersma, Jan Kynčl, et al. (+3)
174 [GO] Eurosurveillance 2021―Dec―17 COVID-19 trends and severity among symptomatic children aged 0-17 years in 10 European Union countries, 3 August 2020 to 3 October 2021 Nick Bundle, Nishi Dave, Anastasia Pharris, Gianfranco Spiteri, Charlotte Deogan, Jonathan E Suk
175 [GO] Eurosurveillance 2021―Dec―17 Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020 Shelly Bolotin, Vanessa Tran, Shelley L Deeks, Adriana Peci, Kevin A Brown, Sarah A Buchan, et al. (+13)
176 [GO] Eurosurveillance 2021―Dec―17 Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021 Laura Espenhain, Tjede Funk, Maria Overvad, Sofie Marie Edslev, Jannik Fonager, Anna Cäcilia Ingham, et al. (+23)
177 [GO] Eurosurveillance 2021―Dec―17 Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021 Lin T. Brandal, Emily MacDonald, Lamprini Veneti, Tine Ravlo, Heidi Lange, Umaer Naseer, et al. (+14)
178 [GO] Eurosurveillance 2021―Dec―10 Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021 Carl Suetens, Pete Kinross, Pilar Gallego Berciano, Virginia Arroyo Nebreda, Eline Hassan, Clémentine Calba, et al. (+23)
179 [GO] Eurosurveillance 2021―Dec―10 Estimating the transmission advantage of the D614G mutant strain of SARS-CoV-2, December 2019 to June 2020 Kathy Leung, Yao Pei, Gabriel M Leung, Tommy TY Lam, Joseph T Wu
180 [GO] Eurosurveillance 2021―Dec―10 Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021 Ria Lassaunière, Charlotta Polacek, Jannik Fonager, Marc Bennedbæk, Lasse Boding, Morten Rasmussen, Anders Fomsgaard
181 [GO] Eurosurveillance 2021―Dec―10 The importance of saturating density dependence for population-level predictions of SARS-CoV-2 resurgence compared with density-independent or linearly density-dependent models, England, 23 March to 31 July 2020 Emily S Nightingale, Oliver J Brady, Laith Yakob
182 [GO] Eurosurveillance 2021―Dec―03 The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A seroprevalence study, June to July 2020 Laura Heavey, Patricia Garvey, Aoife M Colgan, Lelia Thornton, Jeff Connell, Thomas Roux, et al. (+10)
183 [GO] Eurosurveillance 2021―Dec―03 Establishing an ad hoc COVID-19 mortality surveillance during the first epidemic wave in Belgium, 1 March to 21 June 2020 Françoise Renard, Aline Scohy, Johan Van der Heyden, Ilse Peeters, Sara Dequeker, Eline Vandael, et al. (+9)
184 [GO] Eurosurveillance 2021―Dec―03 Initial assessment of the COVID-19 vaccination’s impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021 Nathalie Nicolay, Francesco Innocenti, Julien Beauté, Veronika Učakar, Marta Grgič Vitek, Eero Poukka, et al. (+18)
185 [GO] Eurosurveillance 2021―Dec―03 Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study Yaniv Lustig, Carmit Cohen, Asaf Biber, Hanaa Jaber, Yael Becker Ilany, Victoria Indenbaum, et al. (+4)
186 [GO] Eurosurveillance 2021―Dec―03 Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021 Victoria Indenbaum, Yaniv Lustig, Ella Mendelson, Yael Hershkovitz, Aharona Glatman-Freedman, Lital Keinan-Boker, Ravit Bassal
187 [GO] Eurosurveillance 2021―Dec―03 Surge in SARS-CoV-2 transmission in school-aged children and household contacts, England, August to October 2021 Dimple Y Chudasama, Elise Tessier, Joe Flannagan, David Leeman, Harriet Webster, Alicia Demirjian, et al. (+7)
188 [GO] Eurosurveillance 2021―Nov―26 Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January-September 2021 Chiara Sacco, Alberto Mateo-Urdiales, Daniele Petrone, Matteo Spuri, Massimo Fabiani, Maria Fenicia Vescio, et al. (+5)
189 [GO] Eurosurveillance 2021―Nov―26 Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021 Margaux MI Meslé, Jeremy Brown, Piers Mook, José Hagan, Roberta Pastore, Nick Bundle, et al. (+22)
190 [GO] Eurosurveillance 2021―Nov―19 Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021 Rebecca Giddings, Maria Krutikov, Tom Palmer, Christopher Fuller, Borscha Azmi, Madhumita Shrotri, et al. (+5)
191 [GO] Eurosurveillance 2021―Nov―19 Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020 Liselotte Diaz Högberg, Vera Vlahović-Palčevski, Cátia Pereira, Klaus Weist, Dominique L Monnet
192 [GO] Eurosurveillance 2021―Nov―12 Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021 Kimberley SM Benschop, Jan Albert, Andres Anton, Cristina Andrés, Maitane Aranzamendi, Brynja Armannsdóttir, et al. (+74)
193 [GO] Eurosurveillance 2021―Nov―12 Measuring diagnostic performance of COVID-19 tests: lessons for the next pandemic Jacob Moran-Gilad
194 [GO] Eurosurveillance 2021―Nov―12 The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021 Neta Zuckerman, Ital Nemet, Limor Kliker, Nofar Atari, Yaniv Lustig, Efrat Bucris, et al. (+14)
195 [GO] Eurosurveillance 2021―Nov―12 Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid and antibody tests up to 22 August 2020 Ivo Van Walle, Katrin Leitmeyer, Eeva K Broberg
196 [GO] Eurosurveillance 2021―Nov―05 Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 Andreas Puyskens, Eva Krause, Janine Michel, C Micha Nübling, Heinrich Scheiblauer, Daniel Bourquain, et al. (+15)
197 [GO] Eurosurveillance 2021―Nov―05 Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 Heinrich Scheiblauer, Angela Filomena, Andreas Nitsche, Andreas Puyskens, Victor M Corman, Christian Drosten, et al. (+6)
198 [GO] Eurosurveillance 2021―Nov―05 The impact of public health interventions in the Nordic countries during the first year of SARS-CoV-2 transmission and evolution Sebastian Duchene, Leo Featherstone, Birgitte Freiesleben de Blasio, Edward C Holmes, Jon Bohlin, John H-O Pettersson
199 [GO] Eurosurveillance 2021―Nov―05 Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021 Brechje de Gier, Stijn Andeweg, Jantien A Backer, Susan JM Hahné, Susan van den Hof, Hester E de Melker, Mirjam J Knol
200 [GO] Eurosurveillance 2021―Oct―29 A longitudinal study on symptom duration and 60-day clinical course in non-hospitalised COVID-19 cases in Berlin, Germany, March to May, 2020 Neil J. Saad, Felix Moek, Fabienne Steitz, Lukas Murajda, Till Bärnighausen, Thomas Zoller, et al. (+2)
201 [GO] Eurosurveillance 2021―Oct―29 Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020 Maximilian Muenchhoff, Alexander Graf, Stefan Krebs, Caroline Quartucci, Sandra Hasmann, Johannes Hellmuth, et al. (+32)
202 [GO] Eurosurveillance 2021―Oct―22 The four weeks before lockdown during the COVID-19 pandemic in Germany: a weekly serial cross-sectional survey on risk perceptions, knowledge, public trust and behaviour, 3 to 25 March 2020 Cornelia Betsch, Lars Korn, Tanja Burgard, Wolfgang Gaissmaier, Lisa Felgendreff, Sarah Eitze, et al. (+10)
203 [GO] Eurosurveillance 2021―Oct―22 Enhanced national surveillance of severe acute respiratory infections (SARI) within COVID-19 surveillance, Slovenia, weeks 13 to 37 2021 Irena Klavs, Mojca Serdt, Veronika Učakar, Marta Grgič-Vitek, Mario Fafangel, Maja Mrzel, et al. (+7)
204 [GO] Eurosurveillance 2021―Oct―22 Rapid, dose-dependent and efficient inactivation of surface dried SARS-CoV-2 by 254 nm UV-C irradiation Natalia Ruetalo, Ramona Businger, Michael Schindler
205 [GO] Eurosurveillance 2021―Oct―15 COVID-19 outbreak among French firefighters, Marseille, France, 2020 Guillaume André Durand, Franck de Laval, Albane de Bonet d’Oléon, François Xavier Le Flem, Yann Morin, Cyril Badaut, et al. (+11)
206 [GO] Eurosurveillance 2021―Oct―15 Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021 Thomas Harder, Wiebe Külper-Schiek, Sarah Reda, Marina Treskova-Schwarzbach, Judith Koch, Sabine Vygen-Bonnet, Ole Wichmann
207 [GO] Eurosurveillance 2021―Oct―15 Preparing for an influenza season 2021/22 with a likely co-circulation of influenza virus and SARS-CoV-2 Amparo Larrauri, Katarina Prosenc Trilar
208 [GO] Eurosurveillance 2021―Oct―08 Spotlight influenza: The 2019/20 influenza season and the impact of COVID-19 on influenza surveillance in the WHO European Region Cornelia Adlhoch, Miriam Sneiderman, Oksana Martinuka, Angeliki Melidou, Nick Bundle, James Fielding, et al. (+4)
209 [GO] Eurosurveillance 2021―Oct―08 Long time frames to detect the impact of changing COVID-19 measures, Canada, March to July 2020 Jessica E Stockdale, Renny Doig, Joosung Min, Nicola Mulberry, Liangliang Wang, Lloyd T Elliott, Caroline Colijn
210 [GO] Eurosurveillance 2021―Oct―08 Occupational risk of COVID-19 in the first versus second epidemic wave in Norway, 2020 Karin Magnusson, Karin Nygård, Fredrik Methi, Line Vold, Kjetil Telle
211 [GO] Eurosurveillance 2021―Oct―08 Supplementing SARS-CoV-2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021 Richard Molenkamp, Ewout Fanoy, Leonie Derickx, Theun de Groot, Marcel Jonges, Tjalling Leenstra, et al. (+6)
212 [GO] Eurosurveillance 2021―Oct―01 Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021 Iván Martínez-Baz, Camino Trobajo-Sanmartín, Ana Miqueleiz, Marcela Guevara, Miguel Fernández-Huerta, Cristina Burgui, et al. (+5)
213 [GO] Eurosurveillance 2021―Oct―01 Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021 Pnina Shitrit, Neta S Zuckerman, Orna Mor, Bat-Sheva Gottesman, Michal Chowers
214 [GO] Eurosurveillance 2021―Oct―01 Expansion of a SARS-CoV-2 Delta variant with an 872 nt deletion encompassing ORF7a, ORF7b and ORF8, Poland, July to August 2021 Natalia Mazur-Panasiuk, Lukasz Rabalski, Tomasz Gromowski, Grzegorz Nowicki, Michal Kowalski, Witold Wydmanski, et al. (+12)
215 [GO] Eurosurveillance 2021―Oct―01 Strategies to reduce the risk of SARS-CoV-2 importation from international travellers: modelling estimations for the United Kingdom, July 2020 Samuel Clifford, Billy J Quilty, Timothy W Russell, Yang Liu, Yung-Wai D Chan, Carl A B Pearson, et al. (+4)
216 [GO] Eurosurveillance 2021―Sep―24 COVID-19 outbreak investigation and response in a penitentiary setting: the experience of a prison in Italy, February to April 2020 Ruggero Giuliani, Cristina Cairone, Lara Tavoschi, Laura Ciaffi, Teresa Sebastiani, Raffaella Bartolotti, et al. (+3)
217 [GO] Eurosurveillance 2021―Sep―24 mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021 Baltazar Nunes, Ana Paula Rodrigues, Irina Kislaya, Camila Cruz, André Peralta-Santos, João Lima, et al. (+4)
218 [GO] Eurosurveillance 2021―Sep―17 Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 2021 François Blanquart, Clémence Abad, Joëvin Ambroise, Mathieu Bernard, Gina Cosentino, Jean-Marc Giannoli, Florence Débarre
219 [GO] Eurosurveillance 2021―Sep―10 Understanding a national increase in COVID-19 vaccination intention, the Netherlands, November 2020-March 2021 Jet G. Sanders, Pita Spruijt, Mart van Dijk, Janneke Elberse, Mattijs S. Lambooij, Floor M. Kroese, Marijn de Bruin
220 [GO] Eurosurveillance 2021―Sep―03 Letter to the editor: More data on vaccine efficacy/effectiveness of COVID-19 vaccines against asymptomatic SARS-CoV-2 infection Ying-Wen Chen, Wen-Chien Ko
221 [GO] Eurosurveillance 2021―Sep―03 Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, Wiebe Külper-Schiek, Antonia Pilic, Sarah Reda, et al. (+2)
222 [GO] Eurosurveillance 2021―Aug―27 SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020 Stefanie Theuring, Marlene Thielecke, Welmoed van Loon, Franziska Hommes, Claudia Hülso, Annkathrin von der Haar, et al. (+10)
223 [GO] Eurosurveillance 2021―Aug―27 Sensitivity and specificity of the antigen-based anterior nasal self-testing programme for detecting SARS-CoV-2 infection in schools, Austria, March 2021 Peter Willeit, Benoît Bernar, Christoph Zurl, Mariam Al-Rawi, Andrea Berghold, David Bernhard, et al. (+16)
224 [GO] Eurosurveillance 2021―Aug―20 Determinants for hospitalisations, intensive care unit admission and death among 20,293 reported COVID-19 cases in Portugal, March to April 2020 Vasco Ricoca Peixoto, André Vieira, Pedro Aguiar, Paulo Sousa, Carlos Carvalho, Daniel Thomas, et al. (+2)
225 [GO] Eurosurveillance 2021―Aug―20 Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021 Eunju Lee, Yeon-kyeong Lee, Tae Eun Kim, Insob Hwang, Yeon Haw Jung, Hye Ryeon Lee, et al. (+4)
226 [GO] Eurosurveillance 2021―Aug―06 Contributions of the EURO 2020 football championship events to a third wave of SARS-CoV-2 in Scotland, 11 June to 7 July 2021 Kimberly Marsh, Emily Griffiths, Johanna J. Young, Carrie-Anne Gibb, Jim McMenamin
227 [GO] Eurosurveillance 2021―Aug―06 Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021 Brechje de Gier, Stijn Andeweg, Rosa Joosten, Ronald ter Schegget, Naomi Smorenburg, Jan van de Kassteele, et al. (+4)
228 [GO] Eurosurveillance 2021―Jul―30 Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021 Inge Kroidl, Ingo Mecklenburg, Peter Schneiderat, Katharina Müller, Philipp Girl, Roman Wölfel, et al. (+4)
229 [GO] Eurosurveillance 2021―Jul―30 An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021 Iivo Hetemäki, Sohvi Kääriäinen, Pirjo Alho, Janne Mikkola, Carita Savolainen-Kopra, Niina Ikonen, et al. (+2)
230 [GO] Eurosurveillance 2021―Jul―23 Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic Thomas C. Williams, Ian Sinha, Ian G. Barr, Maria Zambon
231 [GO] Eurosurveillance 2021―Jul―23 Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020 Stefano Tempia, Sibongile Walaza, Jinal N Bhiman, Meredith L McMorrow, Jocelyn Moyes, Thulisa Mkhencele, et al. (+18)
232 [GO] Eurosurveillance 2021―Jul―23 Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021 Moran Weinberger Opek, Yonatan Yeshayahu, Aharona Glatman-Freedman, Zalman Kaufman, Nadav Sorek, Tal Brosh-Nissimov
233 [GO] Eurosurveillance 2021―Jul―23 Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 Esther Kissling, Mariette Hooiveld, Virginia Sandonis Martín, Iván Martínez-Baz, Naoma William, Ana-Maria Vilcu, et al. (+34)
234 [GO] Eurosurveillance 2021―Jul―16 Impact of non-pharmaceutical interventions against COVID-19 in Europe in 2020: a quasi-experimental non-equivalent group and time series design study Paul R Hunter, Felipe J Colón-González, Julii Brainard, Steven Rushton
235 [GO] Eurosurveillance 2021―Jul―16 Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England Annabel A Powell, Linda Power, Samantha Westrop, Kelsey McOwat, Helen Campbell, Ruth Simmons, et al. (+4)
236 [GO] Eurosurveillance 2021―Jul―16 Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021 Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, Wiebe Külper-Schiek, Antonia Pilic, Sarah Reda, et al. (+2)
237 [GO] Eurosurveillance 2021―Jul―16 Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021 Samuel Alizon, Stéphanie Haim-Boukobza, Vincent Foulongne, Laura Verdurme, Sabine Trombert-Paolantoni, Emmanuel Lecorche, et al. (+2)
238 [GO] Eurosurveillance 2021―Jul―09 An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021 Sarah V Williams, Amoolya Vusirikala, Shamez N Ladhani, Elena Fernandez Ruiz De Olano, Nalini Iyanger, Felicity Aiano, et al. (+10)
239 [GO] Eurosurveillance 2021―Jul―09 Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021 Kimihito Ito, Chayada Piantham, Hiroshi Nishiura
240 [GO] Eurosurveillance 2021―Jul―09 SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data Dung Nguyen, Peter Simmonds, Maurice Steenhuis, Elise Wouters, Daniel Desmecht, Mutien Garigliany, et al. (+26)
241 [GO] Eurosurveillance 2021―Jul―02 Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021 Cécile Tran Kiem, Alessio Andronico, Paolo Bosetti, Juliette Paireau, Lise Alter, Pierre-Yves Boëlle, et al. (+3)
242 [GO] Eurosurveillance 2021―Jun―25 Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021 Alberto Mateo-Urdiales, Stefania Spila Alegiani, Massimo Fabiani, Patrizio Pezzotti, Antonietta Filia, Marco Massari, et al. (+12)
243 [GO] Eurosurveillance 2021―Jun―18 Time to regain lost ground: Tuberculosis in the COVID-19 era Dominik Zenner
244 [GO] Eurosurveillance 2021―Jun―18 Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021 Clara Mazagatos, Susana Monge, Carmen Olmedo, Lorena Vega, Pilar Gallego, Elisa Martín-Merino, et al. (+3)
245 [GO] Eurosurveillance 2021―Jun―18 Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020 Florian P Maurer, Natalia Shubladze, Gulmira Kalmambetova, Irina Felker, Giorgi Kuchukhidze, Francis Drobniewski, et al. (+2)
246 [GO] Eurosurveillance 2021―Jun―18 Early COVID-19 pandemic’s toll on tuberculosis services, WHO European Region, January to June 2020 Masoud Dara, Giorgi Kuchukhidze, Askar Yedilbayev, Ihor Perehinets, Tanja Schmidt, W. Leif Van Grinsven, Martin J. Boeree
247 [GO] Eurosurveillance 2021―Jun―18 Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021 Finlay Campbell, Brett Archer, Henry Laurenson-Schafer, Yuka Jinnai, Franck Konings, Neale Batra, et al. (+6)
248 [GO] Eurosurveillance 2021―Jun―11 Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021 Jochem B Buil, Arthur R H van Zanten, Robbert G Bentvelsen, Tom A Rijpstra, Bram Goorhuis, Sanne van der Voort, et al. (+7)
249 [GO] Eurosurveillance 2021―Jun―11 The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021 Bénédicte Roquebert, Sabine Trombert-Paolantoni, Stéphanie Haim-Boukobza, Emmanuel Lecorche, Laura Verdurme, Vincent Foulongne, et al. (+2)
250 [GO] Eurosurveillance 2021―Jun―04 Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study Cécile Tran Kiem, Pascal Crépey, Paolo Bosetti, Daniel Levy Bruhl, Yazdan Yazdanpanah, Henrik Salje, et al. (+2)
251 [GO] Eurosurveillance 2021―Jun―04 Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and Sweden Hanne-Dorthe Emborg, AnnaSara Carnahan, Karoline Bragstad, Ramona Trebbien, Mia Brytting, Olav Hungnes, et al. (+2)
252 [GO] Eurosurveillance 2021―May―28 Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021 Iván Martínez-Baz, Ana Miqueleiz, Itziar Casado, Ana Navascués, Camino Trobajo-Sanmartín, Cristina Burgui, et al. (+3)
253 [GO] Eurosurveillance 2021―May―28 SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021 Anna Loenenbach, Inessa Markus, Ann-Sophie Lehfeld, Matthias an der Heiden, Walter Haas, Maya Kiegele, et al. (+6)
254 [GO] Eurosurveillance 2021―May―26 Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020 Charlotte Kaeuffer, Coralie Le Hyaric, Thibaut Fabacher, Joy Mootien, Benjamin Dervieux, Yvon Ruch, et al. (+12)
255 [GO] Eurosurveillance 2021―May―26 Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case–control study, Paris, France, April to May 2020 Julie Toubiana, Corinne Levy, Slimane Allali, Camille Jung, Marianne Leruez-Ville, Emmanuelle Varon, et al. (+9)
256 [GO] Eurosurveillance 2021―May―21 Epidemiological characteristics and outcomes of COVID-19 cases: mortality inequalities by socio-economic status, Barcelona, Spain, 24 February to 4 May 2020 Julieta Politi, Mario Martín-Sánchez, Lilas Mercuriali, Blanca Borras-Bermejo, Joaquín Lopez-Contreras, Anna Vilella, et al. (+4)
257 [GO] Eurosurveillance 2021―May―21 The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant David Hodgson, Stefan Flasche, Mark Jit, Adam J Kucharski
258 [GO] Eurosurveillance 2021―May―07 The silent epidemic of lymphogranuloma venereum inside the COVID-19 pandemic in Madrid, Spain, March 2020 to February 2021 Laura Martínez-García, Mario Rodríguez-Domínguez, Clara Lejarraga, María Concepción Rodríguez-Jiménez, José María González-Alba, Teresa Puerta, et al. (+4)
259 [GO] Eurosurveillance 2021―May―07 Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021 Thérèse Staub, Vic Arendt, Esther Calvo Lasso de la Vega, Pierre Braquet, Christian Michaux, Michel Kohnen, et al. (+4)
260 [GO] Eurosurveillance 2021―Apr―30 No country or continent is on its own in the ongoing COVID-19 pandemic Kari Johansen, Hanna Nohynek
261 [GO] Eurosurveillance 2021―Apr―30 National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines Sarah R Williams, Amanda J Driscoll, Hanna M LeBuhn, Wilbur H Chen, Kathleen M Neuzil, Justin R Ortiz
262 [GO] Eurosurveillance 2021―Apr―30 Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021 Massimo Fabiani, Mauro Ramigni, Valentina Gobbetto, Alberto Mateo-Urdiales, Patrizio Pezzotti, Cinzia Piovesan
263 [GO] Eurosurveillance 2021―Apr―23 Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021 Sabrina Jungnick, Bernhard Hobmaier, Lena Mautner, Mona Hoyos, Maren Haase, Armin Baiker, et al. (+12)
264 [GO] Eurosurveillance 2021―Apr―23 Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 Tjede Funk, Anastasia Pharris, Gianfranco Spiteri, Nick Bundle, Angeliki Melidou, Michael Carr, et al. (+32)
265 [GO] Eurosurveillance 2021―Apr―16 Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France Laura Di Domenico, Chiara E Sabbatini, Giulia Pullano, Daniel Lévy-Bruhl, Vittoria Colizza
266 [GO] Eurosurveillance 2021―Apr―16 SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020 Arnaud Fontanet, Laura Tondeur, Rebecca Grant, Sarah Temmam, Yoann Madec, Thomas Bigot, et al. (+21)
267 [GO] Eurosurveillance 2021―Apr―09 Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 Marzia Lazzerini, Idanna Sforzi, Sandra Trapani, Paolo Biban, Davide Silvagni, Giovanna Villa, et al. (+36)
268 [GO] Eurosurveillance 2021―Apr―09 Determining the communicable period of SARS-CoV-2: A rapid review of the literature, March to September 2020 Mina Park, Colleen Pawliuk, Tribesty Nguyen, Amanda Griffitt, Linda Dix-Cooper, Nadia Fourik, Martin Dawes
269 [GO] Eurosurveillance 2021―Apr―02 Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020 Isabelle Sermet-Gaudelus, Sarah Temmam, Christèle Huon, Sylvie Behillil, Vincent Gajdos, Thomas Bigot, et al. (+28)
270 [GO] Eurosurveillance 2021―Apr―02 Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021
271 [GO] Eurosurveillance 2021―Mar―30 Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus H Nishiura, K Mizumoto, M Ejima, Y Zhong, B J Cowling, R Omori
272 [GO] Eurosurveillance 2021―Mar―30 Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012 A Bermingham, M A Chand, C S Brown, E Aarons, C Tong, C Langrish, et al. (+13)
273 [GO] Eurosurveillance 2021―Mar―30 The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012 R G Pebody, M A Chand, H L Thomas, H K Green, N L Boddington, C Carvalho, et al. (+20)
274 [GO] Eurosurveillance 2021―Mar―30 Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012 U Buchholz, M A Müller, A Nitsche, A Sanewski, N Wevering, T Bauer-Balci, et al. (+10)
275 [GO] Eurosurveillance 2021―Mar―30 Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart S Cauchemez, M D Van Kerkhove, S Riley, C A Donnelly, C Fraser, N M Ferguson
276 [GO] Eurosurveillance 2021―Mar―30 First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013 A Mailles, K Blanckaert, P Chaud, S van der Werf, B Lina, V Caro, et al. (+21)
277 [GO] Eurosurveillance 2021―Mar―30 Experiences of giving oseltamivir to school children during the 2009 influenza A(H1N1) pandemic J Giesecke
278 [GO] Eurosurveillance 2021―Mar―30 The vaccination campaign against 2009 pandemic influenza A(H1N1) and its continued importance in view of the uncertainty surrounding the risk associated with the pandemic S Tsiodras, V Sypsa, A Hatzakis
279 [GO] Eurosurveillance 2021―Mar―30 The end of the pandemic - what will be the pattern of influenza in the 2010-11 European winter and beyond? A Nicoll, M Sprenger
280 [GO] Eurosurveillance 2021―Mar―30 Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010 O Lyytikaïnen, M Kuusi, M Snellman, M J Virtanen, J Eskola, E Rönkkö, et al. (+4)
281 [GO] Eurosurveillance 2021―Mar―30 Pandemic H1N1 influenza: predicting the course of a pandemic and assessing the efficacy of the planned vaccination programme in the United States S Towers, Z Feng
282 [GO] Eurosurveillance 2021―Mar―30 Hospitalisation associated with the 2009 H1N1 pandemic and seasonal influenza in Hong Kong, 2005 to 2010 L Yang, X L Wang, K P Chan, P H Cao, H Y Lau, J S Peiris, C M Wong
283 [GO] Eurosurveillance 2021―Mar―30 Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010 P Hardelid, D M Fleming, J McMenamin, N Andrews, C Robertson, P Sebastianpillai, et al. (+5)
284 [GO] Eurosurveillance 2021―Mar―30 Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany J P Cramer, T Mac, B Hogan, S Stauga, S Eberhardt, O Wichmann, et al. (+2)
285 [GO] Eurosurveillance 2021―Mar―30 Web query-based surveillance in Sweden during the influenza A(H1N1)2009 pandemic, April 2009 to February 2010 A Hulth, G Rydevik
286 [GO] Eurosurveillance 2021―Mar―30 Estimating influenza-related sick leave in Norway: Was work absenteeism higher during the 2009 A(H1N1) pandemic compared to seasonal epidemics? B F de Blasio, Y Xue, B Iversen, J Michael Gran
287 [GO] Eurosurveillance 2021―Mar―30 Influenza-associated hospitalisations in Finland from 1996 to 2010: unexpected age-specific burden during the influenza A(H1N1)pdm09 pandemic from 2009 to 2010 A Jacks, J Ollgren, T Ziegler, O Lyytikäinen
288 [GO] Eurosurveillance 2021―Mar―30 Behaviours regarding preventive measures against pandemic H1N1 influenza among Italian healthcare workers, October 2009 G La Torre, D Di Thiene, C Cadeddu, W Ricciardi, A Boccia
289 [GO] Eurosurveillance 2021―Mar―30 Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April - 3 October 2009 G Cullen, J Martin, J O’Donnell, M Boland, M Canny, E Keane, et al. (+6)
290 [GO] Eurosurveillance 2021―Mar―30 Measures against transmission of pandemic H1N1 influenza in Japan in 2009: simulation model H Yasuda, K Suzuki
291 [GO] Eurosurveillance 2021―Mar―30 Behaviour of the pandemic H1N1 influenza virus in Andalusia, Spain, at the onset of the 2009-10 season J M Mayoral Cortés, L Puell Gómez, E Pérez Morilla, V Gallardo García, E Duran Pla, J C Fernandez Merino, et al. (+7)
292 [GO] Eurosurveillance 2021―Mar―30 Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009 T F Tsai, P Pedotti, A Hilbert, K Lindert, M Hohenboken, A Borkowski, et al. (+3)
293 [GO] Eurosurveillance 2021―Mar―30 Interpreting “Google Flu Trends” data for pandemic H1N1 influenza: The New Zealand experience N Wilson, K Mason, M Tobias, M Peacey, Q S Huang, M Baker
294 [GO] Eurosurveillance 2021―Mar―30 Electronic real-time surveillance for influenza-like illness: experience from the 2009 influenza A(H1N1) pandemic in Denmark K M Harder, P H Andersen, I Bæhr, L P Nielsen, S Ethelberg, S Glismann, K Mølbak
295 [GO] Eurosurveillance 2021―Mar―30 Risk perception and information-seeking behaviour during the 2009/10 influenza A(H1N1)pdm09 pandemic in Germany D Walter, M M Böhmer, S Reiter, G Krause, O Wichmann
296 [GO] Eurosurveillance 2021―Mar―30 Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1)2009 pandemic in the Asia-Pacific region, March 2009 to March 2010 A C Hurt, Y M Deng, J Ernest, N Caldwell, L Leang, P Iannello, et al. (+9)
297 [GO] Eurosurveillance 2021―Mar―30 Early spread of the 2009 influenza A(H1N1) pandemic in the United Kingdom - use of local syndromic data, May-August 2009 S Smith, G E Smith, B Olowokure, S Ibbotson, D Foord, H Maguire, et al. (+4)
298 [GO] Eurosurveillance 2021―Mar―30 Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010 R G Pebody, E McLean, H Zhao, P Cleary, S Bracebridge, K Foster, et al. (+12)
299 [GO] Eurosurveillance 2021―Mar―30 Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010 O Wichmann, P Stöcker, G Poggensee, D Altmann, D Walter, W Hellenbrand, et al. (+2)
300 [GO] Eurosurveillance 2021―Mar―30 Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009 S Jefferies, D Earl, N Berry, T Blackmore, S Rooker, N Raymond, et al. (+4)
301 [GO] Eurosurveillance 2021―Mar―30 Pandemic influenza A(H1N1)2009 in Morocco: experience of the Mohammed V Military Teaching Hospital, Rabat, 12 June to 24 December 2009 I Lahlou Amine, T Bajjou, H El Rhaffouli, A Laraqui, F Hilali, K Menouar, et al. (+7)
302 [GO] Eurosurveillance 2021―Mar―30 Two waves of pandemic influenza A(H1N1)2009 in Wales - the possible impact of media coverage on consultation rates, April - December 2009 M Keramarou, S Cottrell, M R Evans, C Moore, R E Stiff, C Elliott, et al. (+3)
303 [GO] Eurosurveillance 2021―Mar―30 Secondary attack rate of pandemic influenza A(H1N1)2009 in Western Australian households, 29 May-7 August 2009 D Carcione, C M Giele, L S Goggin, K SH Kwan, D W Smith, G K Dowse, et al. (+2)
304 [GO] Eurosurveillance 2021―Mar―30 Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11 R Pebody, P Hardelid, D M Fleming, J McMenamin, N Andrews, C Robertson, et al. (+7)
305 [GO] Eurosurveillance 2021―Mar―30 Pandemic influenza A(H1N1) 2009 vaccines in the European Union K Johansen, A Nicoll, B C Ciancio, P Kramarz
306 [GO] Eurosurveillance 2021―Mar―30 The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009 H Harvala, R Gunson, P Simmonds, A Hardie, S Bennett, F Scott, et al. (+8)
307 [GO] Eurosurveillance 2021―Mar―30 The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009 C C Blyth, A Kelso, K A McPhie, V M Ratnamohan, M Catton, J D Druce, et al. (+7)
308 [GO] Eurosurveillance 2021―Mar―30 Pandemic influenza A(H1N1)2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010 L Malato, V Llavador, E Marmier, J Youssef, C Balick Weber, H Rozé, et al. (+2)
309 [GO] Eurosurveillance 2021―Mar―30 Decrease in number of genital chlamydia cases in Norrbotten, Sweden, October - November 2009: an indirect effect of pandemic influenza A(H1N1)? A Österlund
310 [GO] Eurosurveillance 2021―Mar―30 Low acceptance of vaccination against the 2009 pandemic influenza A(H1N1) among healthcare workers in Greece G Rachiotis, V A Mouchtouri, J Kremastinou, K Gourgoulianis, C Hadjichristodoulou
311 [GO] Eurosurveillance 2021―Mar―30 Characteristics of paediatric patients with 2009 pandemic influenza A(H1N1) and severe, oxygen-requiring pneumonia in the Tokyo region, 1 September-31 October 2009 M Nishiyama, Y Yoshida, M Sato, M Nishioka, T Kato, T Kanai, et al. (+5)
312 [GO] Eurosurveillance 2021―Mar―30 Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison - a serological survey M Aho, O Lyytikaïnen, J E Nyholm, T Kuitunen, E Rönkkö, R Santanen, et al. (+2)
313 [GO] Eurosurveillance 2021―Mar―30 Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom M Strong, J Burrows, E Stedman, P Redgrave
314 [GO] Eurosurveillance 2021―Mar―30 The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010 D Bandaranayake, M Jacobs, M Baker, D Hunt, T Wood, A Bissielo, et al. (+4)
315 [GO] Eurosurveillance 2021―Mar―30 Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations S Paine, G N Mercer, P M Kelly, D Bandaranayake, M G Baker, Q S Huang, et al. (+4)
316 [GO] Eurosurveillance 2021―Mar―30 Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10 R S Miller, A R MacLean, R N Gunson, W F Carman
317 [GO] Eurosurveillance 2021―Mar―30 Case registry systems for pandemic influenza A(H1N1)pdm09 in Europe: are there lessons for the future? J Whelan, K Greenland, M Rondy, W van der Hoek, M Robert-Du Ry van Beest Holle
318 [GO] Eurosurveillance 2021―Mar―30 Surveillance of hospitalised patients with influenza-like illness during pandemic influenza A(H1N1) season in Sicily, April 2009 - December 2010 F Tramuto, C M Maida, F Bonura, A M Perna, S Puzelli, M A De Marco, et al. (+6)
319 [GO] Eurosurveillance 2021―Mar―30 Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: a modelling study to assess the impact of vaccination timing and prioritisation strategies V Sypsa, I Pavlopoulou, A Hatzakis
320 [GO] Eurosurveillance 2021―Mar―30 Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France I Pelletier, D Rousset, V Enouf, F Colbère-Garapin, S van der Werf, N Naffakh
321 [GO] Eurosurveillance 2021―Mar―30 High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland N Ikonen, M Strengell, L Kinnunen, P Österlund, J Pirhonen, M Broman, et al. (+3)
322 [GO] Eurosurveillance 2021―Mar―30 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak W E Adamson, S Maddi, C Robertson, S McDonagh, P J Molyneaux, K E Templeton, W F Carman
323 [GO] Eurosurveillance 2021―Mar―30 High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009 K Waalen, A Kilander, S G Dudman, G H Krogh, T Aune, O Hungnes
324 [GO] Eurosurveillance 2021―Mar―30 Author's reply: Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease A Kilander, R Rykkvin, S G Dudman, O Hungnes
325 [GO] Eurosurveillance 2021―Mar―30 Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease G C Mak, K W Au, L S Tai, K C Chuang, K C Cheng, T C Shiu, W Lim
326 [GO] Eurosurveillance 2021―Mar―30 New research on pandemic influenza at the World Congress of Epidemiology, Edinburgh, 7-11 August 2011 J A Summers, N Wilson, M G Baker
327 [GO] Eurosurveillance 2021―Mar―30 StatFlu - a static modelling tool for pandemic influenza hospital load for decision makers M Camitz
328 [GO] Eurosurveillance 2021―Mar―30 Quantifying the risk of pandemic influenza in pregnancy and Indigenous people in Australia in 2009 H Kelly, G N Mercer, A C Cheng
329 [GO] Eurosurveillance 2021―Mar―30 Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey V Sypsa, T Livanios, M Psichogiou, M Malliori, S Tsiodras, I Nikolakopoulos, A Hatzakis
330 [GO] Eurosurveillance 2021―Mar―30 “I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9 E Kissling, M Valenciano, J M Falcão, A Larrauri, K Widgren, D Pitigoi, et al. (+7)
331 [GO] Eurosurveillance 2021―Mar―30 The impact of the 2009 influenza A(H1N1) pandemic on attitudes of healthcare workers toward seasonal influenza vaccination 2010/11 C Brandt, H F Rabenau, S Bornmann, R Gottschalk, S Wicker
332 [GO] Eurosurveillance 2021―Mar―30 Estimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain J Castilla, J Etxeberria, E Ardanaz, Y Floristán, R López Escudero, M Guevara
333 [GO] Eurosurveillance 2021―Mar―30 Impact of the 2009 influenza A(H1N1) pandemic on public health workers in the Netherlands L Vinck, L Isken, M Hooiveld, M C Trompenaars, J IJzermans, A Timen
334 [GO] Eurosurveillance 2021―Mar―30 Pandemic phase level 4: human cases of the novel influenza A/H1N1 strain confirmed in Scotland and Spain Collective Editorial team
335 [GO] Eurosurveillance 2021―Mar―30 Multiresistant Salmonella enterica serovar 4,[5],12:i:- in Europe: a new pandemic strain? K L Hopkins, M Kirchner, B Guerra, S A Granier, C Lucarelli, M C Porrero, et al. (+3)
336 [GO] Eurosurveillance 2021―Mar―30 Influenza A(H1N1)pdm09 in England, 2009 to 2011: a greater burden of severe illness in the year after the pandemic than in the pandemic year O T Mytton, P D Rutter, L J Donaldson
337 [GO] Eurosurveillance 2021―Mar―30 Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009 J S Casalegno, M Ottmann, M Bouscambert-Duchamp, M Valette, F Morfin, B Lina
338 [GO] Eurosurveillance 2021―Mar―30 The emerging influenza pandemic: estimating the case fatality ratio N Wilson, M G Baker
339 [GO] Eurosurveillance 2021―Mar―30 Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia D Carcione, C Giele, L S Goggin, K S Kwan, D W Smith, G K Dowse, et al. (+2)
340 [GO] Eurosurveillance 2021―Mar―30 Event-based biosurveillance of respiratory disease in Mexico, 2007-2009: connection to the 2009 influenza A(H1N1) pandemic? N P Nelson, J S Brownstein, D M Hartley
341 [GO] Eurosurveillance 2021―Mar―30 Syndromic surveillance: the next phase of public health monitoring during the H1N1 influenza pandemic? A J Elliot
342 [GO] Eurosurveillance 2021―Mar―30 Rhinoviruses, A(H1N1)v, RSV: The race for hivernal pandemics, France 2009-2010 J S Casalegno, M Bouscambert-Duchamp, F Morfin, B Lina, V Escuret
343 [GO] Eurosurveillance 2021―Mar―26 Robust antibody responses in 70-80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021 Sathyavani Subbarao, Lenesha A Warrener, Katja Hoschler, Keith R Perry, Justin Shute, Heather Whitaker, et al. (+8)
344 [GO] Eurosurveillance 2021―Mar―26 Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil Andreza Francisco Martins, Alexandre Prehn Zavascki, Priscila Lamb Wink, Fabiana Caroline Zempulski Volpato, Francielle Liz Monteiro, Clévia Rosset, et al. (+3)
345 [GO] Eurosurveillance 2021―Mar―19 The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance system Jamie Lopez Bernal, Mary A Sinnathamby, Suzanne Elgohari, Hongxin Zhao, Chinelo Obi, Laura Coughlan, et al. (+23)
346 [GO] Eurosurveillance 2021―Mar―19 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February Daniel J Grint, Kevin Wing, Elizabeth Williamson, Helen I McDonald, Krishnan Bhaskaran, David Evans, et al. (+30)
347 [GO] Eurosurveillance 2021―Mar―12 Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021 María Fernández-Prada, Irene Rivero-Calle, Ana Calvache-González, Federico Martinón-Torres
348 [GO] Eurosurveillance 2021―Mar―12 COVID-19: cross-border contact tracing in Germany, February to April 2020 Inessa Markus, Gyde Steffen, Raskit Lachmann, Adine Marquis, Timm Schneider, Sara Tomczyk, et al. (+7)
349 [GO] Eurosurveillance 2021―Mar―12 Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021 Vítor Borges, Carlos Sousa, Luís Menezes, António Maia Gonçalves, Miguel Picão, José Pedro Almeida, et al. (+15)
350 [GO] Eurosurveillance 2021―Mar―12 Towards a sensitive and accurate interpretation of molecular testing for SARS-CoV-2: a rapid review of 264 studies Kamelia R. Stanoeva, Annemiek A. van der Eijk, Adam Meijer, Laetitia M. Kortbeek, Marion P.G. Koopmans, Chantal B.E.M. Reusken
351 [GO] Eurosurveillance 2021―Mar―05 Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine: results from a population-based prospective cohort in Catalonia, Spain, 2020 Rosa Maria Vivanco-Hidalgo, Israel Molina, Elisenda Martinez, Ramón Roman-Viñas, Adrián Sánchez-Montalvá, Joan Fibla, et al. (+2)
352 [GO] Eurosurveillance 2021―Mar―05 Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021 Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, et al. (+11)
353 [GO] Eurosurveillance 2021―Feb―26 Estimates of mortality attributable to COVID-19: a statistical model for monitoring COVID-19 and seasonal influenza, Denmark, spring 2020 Jens Nielsen, Naja Hulvej Rod, Lasse S Vestergaard, Theis Lange
354 [GO] Eurosurveillance 2021―Feb―26 Impact of physical distancing measures against COVID-19 on contacts and mixing patterns: repeated cross-sectional surveys, the Netherlands, 2016-17, April 2020 and June 2020 Jantien A Backer, Liesbeth Mollema, Eric RA Vos, Don Klinkenberg, Fiona RM van der Klis, Hester E de Melker, et al. (+2)
355 [GO] Eurosurveillance 2021―Feb―19 Letter to the editor: Excess all-cause mortality during second wave of COVID-19 - the Polish perspective Jakub Grabowski, Natalia Witkowska, Leszek Bidzan
356 [GO] Eurosurveillance 2021―Feb―19 Authors’ response: Excess all-cause mortality during second wave of COVID-19 - the Polish perspective Lasse S Vestergaard, Sarah K Nørgaard, Jens Nielsen, Tyra G Krause, Kåre Mølbak
357 [GO] Eurosurveillance 2021―Feb―19 Reducing contacts to stop SARS-CoV-2 transmission during the second pandemic wave in Brussels, Belgium, August to November 2020 Brecht Ingelbeen, Laurène Peckeu, Marie Laga, Ilona Hendrix, Inge Neven, Marianne AB van der Sande, Esther van Kleef
358 [GO] Eurosurveillance 2021―Feb―12 Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021 Kamal Abu Jabal, Hila Ben-Amram, Karine Beiruti, Yunis Batheesh, Christian Sussan, Salman Zarka, Michael Edelstein
359 [GO] Eurosurveillance 2021―Feb―12 Comparison and correlation of commercial SARS-CoV-2 real-time-PCR assays, Ireland, June 2020 Anne Carroll, Eleanor McNamara
360 [GO] Eurosurveillance 2021―Feb―05 Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020 Helle Daugaard Larsen, Jannik Fonager, Frederikke Kristensen Lomholt, Tine Dalby, Guido Benedetti, Brian Kristensen, et al. (+19)
361 [GO] Eurosurveillance 2021―Feb―05 Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020 Anna Jeffery-Smith, Nalini Iyanger, Sarah V Williams, J Yimmy Chow, Felicity Aiano, Katja Hoschler, et al. (+12)
362 [GO] Eurosurveillance 2021―Jan―22 Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020 Antonin Bal, Gregory Destras, Alexandre Gaymard, Karl Stefic, Julien Marlet, Sébastien Eymieux, et al. (+13)
363 [GO] Eurosurveillance 2021―Jan―22 Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020 Pierre Verger, Dimitri Scronias, Nicolas Dauby, Kodzo Awoenam Adedzi, Cathy Gobert, Maxime Bergeat, et al. (+2)
364 [GO] Eurosurveillance 2021―Jan―22 Updated rapid risk assessment from ECDC on the risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update
365 [GO] Eurosurveillance 2021―Jan―15 Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020 Sarah K. Nørgaard, Lasse S. Vestergaard, Jens Nielsen, Lukas Richter, Daniela Schmid, Natalia Bustos, et al. (+52)
366 [GO] Eurosurveillance 2021―Jan―08 Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020 Lin T Brandal, Trine S Ofitserova, Hinta Meijerink, Rikard Rykkvin, Hilde M Lund, Olav Hungnes, et al. (+4)
367 [GO] Eurosurveillance 2021―Jan―08 Control of a COVID-19 outbreak in a nursing home by general screening and cohort isolation in Germany, March to May 2020 Manuel Krone, Annette Noffz, Elisabeth Richter, Ulrich Vogel, Michael Schwab
368 [GO] Eurosurveillance 2021―Jan―08 Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020 Kathy Leung, Marcus HH Shum, Gabriel M Leung, Tommy TY Lam, Joseph T Wu
369 [GO] Eurosurveillance 2021―Jan―08 Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France Paolo Bosetti, Cécile Tran Kiem, Yazdan Yazdanpanah, Arnaud Fontanet, Bruno Lina, Vittoria Colizza, Simon Cauchemez
370 [GO] Eurosurveillance 2020―Dec―18 Early assessment of the impact of mitigation measures to control COVID-19 in 22 French metropolitan areas, October to November 2020 Guillaume Spaccaferri, Sophie Larrieu, Jérôme Pouey, Clémentine Calba, Thomas Benet, Cécile Sommen, et al. (+11)
371 [GO] Eurosurveillance 2020―Dec―18 The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020
372 [GO] Eurosurveillance 2020―Dec―18 Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR Paul S Wikramaratna, Robert S Paton, Mahan Ghafari, José Lourenço
373 [GO] Eurosurveillance 2020―Dec―18 Evaluation of lockdown effect on SARS-CoV-2 dynamics through viral genome quantification in waste water, Greater Paris, France, 5 March to 23 April 2020 S Wurtzer, V Marechal, JM Mouchel, Y Maday, R Teyssou, E Richard, et al. (+2)
374 [GO] Eurosurveillance 2020―Dec―18 Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020 Brechje de Gier, Priscila de Oliveira Bressane Lima, Rolina D van Gaalen, Pieter T de Boer, Jeroen Alblas, Marc Ruijten, et al. (+5)
375 [GO] Eurosurveillance 2020―Dec―11 Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020 Flavia Riccardo, Marco Ajelli, Xanthi D Andrianou, Antonino Bella, Martina Del Manso, Massimo Fabiani, et al. (+22)
376 [GO] Eurosurveillance 2020―Dec―11 Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: a population-based study Elisabetta Larosa, Olivera Djuric, Mariateresa Cassinadri, Silvia Cilloni, Eufemia Bisaccia, Massimo Vicentini, et al. (+4)
377 [GO] Eurosurveillance 2020―Dec―11 Community use of face masks and similar barriers to prevent respiratory illness such as COVID-19: a rapid scoping review Julii Brainard, Natalia R. Jones, Iain R Lake, Lee Hooper, Paul R Hunter
378 [GO] Eurosurveillance 2020―Dec―11 Face masks and COVID-19: don’t let perfect be the enemy of good Benjamin J Cowling, Gabriel M Leung
379 [GO] Eurosurveillance 2020―Nov―27 Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020 Sheena G Sullivan, Sandra Carlson, Allen C Cheng, Monique BN Chilver, Dominic E Dwyer, Melissa Irwin, et al. (+8)
380 [GO] Eurosurveillance 2020―Nov―27 Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020 Daniel Simões, Annemarie Rinder Stengaard, Lauren Combs, Dorthe Raben
381 [GO] Eurosurveillance 2020―Nov―27 Epidemiology and public health response in early phase of COVID-19 pandemic, Veneto Region, Italy, 21 February to 2 April 2020 Francesca Russo, Gisella Pitter, Filippo Da Re, Michele Tonon, Francesco Avossa, Stefania Bellio, et al. (+8)
382 [GO] Eurosurveillance 2020―Nov―27 Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020 Claudia Santos-Hövener, Hannelore K Neuhauser, Angelika Schaffrath Rosario, Markus Busch, Martin Schlaud, Robert Hoffmann, et al. (+17)
383 [GO] Eurosurveillance 2020―Nov―20 Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic Angeliki Melidou, Dmitriy Pereyaslov, Olav Hungnes, Katarina Prosenc, Erik Alm, Cornelia Adlhoch, et al. (+5)
384 [GO] Eurosurveillance 2020―Nov―12 Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance? Dominique L Monnet, Stephan Harbarth
385 [GO] Eurosurveillance 2020―Nov―12 Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020 Jennifer Mehew, Rachel Johnson, David Roberts, Heli Harvala
386 [GO] Eurosurveillance 2020―Oct―22 A large national outbreak of COVID-19 linked to air travel, Ireland, summer 2020 Nicola Murphy, Máirín Boland, Niamh Bambury, Margaret Fitzgerald, Liz Comerford, Niamh Dever, et al. (+5)
387 [GO] Eurosurveillance 2020―Oct―22 What to expect for the influenza season 2020/21 with the ongoing COVID-19 pandemic in the World Health Organization European Region Cornelia Adlhoch, Richard Pebody
388 [GO] Eurosurveillance 2020―Oct―22 SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020 Sheila F Lumley, David W Eyre, Anna L McNaughton, Alison Howarth, Sarah Hoosdally, Stephanie B Hatch, et al. (+30)
389 [GO] Eurosurveillance 2020―Oct―22 Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 Craig P Thompson, Nicholas E Grayson, Robert S Paton, Jai S Bolton, José Lourenço, Bridget S Penman, et al. (+30)
390 [GO] Eurosurveillance 2020―Oct―08 Epidemiological parameters of COVID-19 and its implication for infectivity among patients in China, 1 January to 11 February 2020 Qing-Bin Lu, Yong Zhang, Ming-Jin Liu, Hai-Yang Zhang, Neda Jalali, An-Ran Zhang, et al. (+25)
391 [GO] Eurosurveillance 2020―Oct―01 SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene Katharina Ziegler, Philipp Steininger, Renate Ziegler, Jörg Steinmann, Klaus Korn, Armin Ensser
392 [GO] Eurosurveillance 2020―Sep―24 Peer Review Week 2020: Eurosurveillance thanks all COVID-19 reviewers for their amazing work
393 [GO] Eurosurveillance 2020―Sep―24 Surveillance of COVID-19 school outbreaks, Germany, March to August 2020 Eveline Otte im Kampe, Ann-Sophie Lehfeld, Silke Buda, Udo Buchholz, Walter Haas
394 [GO] Eurosurveillance 2020―Sep―17 Letter to the editor: COVID-19 cases among school-aged children and school-based measures in Hong Kong, July 2020 MW Fong, BJ Cowling, GM Leung, P Wu
395 [GO] Eurosurveillance 2020―Sep―17 Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020 Anneke Steens, Birgitte Freiesleben de Blasio, Lamprini Veneti, Amy Gimma, W John Edmunds, Kevin Van Zandvoort, et al. (+3)
396 [GO] Eurosurveillance 2020―Sep―17 Travel-associated COVID-19: a challenge for surveillance? Julien Beauté, Gianfranco Spiteri
397 [GO] Eurosurveillance 2020―Sep―10 Reduced maximal aerobic capacity after COVID-19 in young adult recruits, Switzerland, May 2020 Giovanni Andrea Gerardo Crameri, Michel Bielecki, Roland Züst, Thomas Werner Buehrer, Zeno Stanga, Jeremy Werner Deuel
398 [GO] Eurosurveillance 2020―Sep―10 Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany J Ehrhardt, A Ekinci, H Krehl, M Meincke, I Finci, J Klein, et al. (+4)
399 [GO] Eurosurveillance 2020―Sep―03 COVID-19 outbreaks in a transmission control scenario: challenges posed by social and leisure activities, and for workers in vulnerable conditions, Spain, early summer 2020
400 [GO] Eurosurveillance 2020―Aug―27 Excess all-cause mortality during the first wave of the COVID-19 epidemic in France, March to May 2020 Anne Fouillet, Isabelle Pontais, Céline Caserio-Schönemann
401 [GO] Eurosurveillance 2020―Aug―27 Timely monitoring of total mortality associated with COVID-19: informing public health and the public Lasse S Vestergaard, Kåre Mølbak
402 [GO] Eurosurveillance 2020―Aug―20 Three infection clusters related with potential pre-symptomatic transmission of coronavirus disease (COVID-19), Shanghai, China, January to February 2020 Xiaohuan Gong, Wenjia Xiao, Yan Cui, Yuanping Wang, Dechuan Kong, Shenghua Mao, et al. (+9)
403 [GO] Eurosurveillance 2020―Aug―13 Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 Anika Singanayagam, Monika Patel, Andre Charlett, Jamie Lopez Bernal, Vanessa Saliba, Joanna Ellis, et al. (+3)
404 [GO] Eurosurveillance 2020―Aug―13 Updated rapid risk assessment from ECDC on coronavirus disease (COVID-19) pandemic in the EU/EEA and the UK: resurgence of cases
405 [GO] Eurosurveillance 2020―Aug―13 Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 Erik Alm, Eeva K Broberg, Thomas Connor, Emma B Hodcroft, Andrey B Komissarov, Sebastian Maurer-Stroh, et al. (+4)
406 [GO] Eurosurveillance 2020―Aug―06 Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020 Nathalie Nicolay, Grazina Mirinaviciute, Thomas Mollet, Lucia Pastore Celentano, Sabrina Bacci
407 [GO] Eurosurveillance 2020―Aug―06 Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 Zacharoula Bogogiannidou, Alexandros Vontas, Katerina Dadouli, Maria A Kyritsi, Soteris Soteriades, Dimitrios J Nikoulis, et al. (+13)
408 [GO] Eurosurveillance 2020―Aug―06 Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020 Piero Poletti, Marcello Tirani, Danilo Cereda, Filippo Trentini, Giorgio Guzzetta, Valentina Marziano, et al. (+10)
409 [GO] Eurosurveillance 2020―Jul―30 Legionella pneumonia: increased risk after COVID-19 lockdown? Italy, May to June 2020 Claudia Palazzolo, Gaetano Maffongelli, Alessandra D’Abramo, Luciana Lepore, Andrea Mariano, Antonella Vulcano, et al. (+5)
410 [GO] Eurosurveillance 2020―Jul―30 Duration of SARS-CoV-2 RNA detection in COVID-19 patients in home isolation, Rhineland-Palatinate, Germany, 2020 - an interval-censored survival analysis Sarah Omar, Christoph Bartz, Sabine Becker, Silke Basenach, Sandra Pfeifer, Corinna Trapp, et al. (+11)
411 [GO] Eurosurveillance 2020―Jul―30 Authors’ response: COVID-19: how accurate are seroprevalence studies? Irene Cassaniti, Elena Percivalle, Antonella Sarasini, Giuseppe Cambiè, Gherard Batisti Biffignandi, Danilo Cereda, Fausto Baldanti
412 [GO] Eurosurveillance 2020―Jul―30 Letter to the editor: COVID-19: how accurate are seroprevalence studies? Kamran Kadkhoda
413 [GO] Eurosurveillance 2020―Jul―23 Letter to the editor: Generation interval for COVID-19 based on symptom onset data Sergio Bacallado, Qingyuan Zhao, Nianqiao Ju
414 [GO] Eurosurveillance 2020―Jul―23 Authors’ response: Estimating the generation interval for COVID-19 based on symptom onset data Cécile Kremer, Tapiwa Ganyani, Dongxuan Chen, Andrea Torneri, Christel Faes, Jacco Wallinga, Niel Hens
415 [GO] Eurosurveillance 2020―Jul―23 A large COVID-19 outbreak in a high school 10 days after schools’ reopening, Israel, May 2020 Chen Stein-Zamir, Nitza Abramson, Hanna Shoob, Erez Libal, Menachem Bitan, Tanya Cardash, et al. (+2)
416 [GO] Eurosurveillance 2020―Jul―16 All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England Mary A Sinnathamby, Heather Whitaker, Laura Coughlan, Jamie Lopez Bernal, Mary Ramsay, Nick Andrews
417 [GO] Eurosurveillance 2020―Jul―16 Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2 Zhiqiang Zheng, Vanessa Marthe Monteil, Sebastian Maurer-Stroh, Chow Wenn Yew, Carol Leong, Nur Khairiah Mohd-Ismail, et al. (+6)
418 [GO] Eurosurveillance 2020―Jul―16 SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020 Bastian Fischer, Cornelius Knabbe, Tanja Vollmer
419 [GO] Eurosurveillance 2020―Jul―16 Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020 Heli Harvala, Jennifer Mehew, Matthew L Robb, Samreen Ijaz, Steven Dicks, Monika Patel, et al. (+7)
420 [GO] Eurosurveillance 2020―Jul―09 International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020 Veerle Matheeussen, Victor M Corman, Oliver Donoso Mantke, Elaine McCulloch, Christine Lammens, Herman Goossens, et al. (+6)
421 [GO] Eurosurveillance 2020―Jul―02 Rapid risk assessment from ECDC: Resurgence of reported cases of COVID-19 in the EU/EEA, the UK and EU candidate and potential candidate countries
422 [GO] Eurosurveillance 2020―Jul―02 Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020 Lasse S Vestergaard, Jens Nielsen, Lukas Richter, Daniela Schmid, Natalia Bustos, Toon Braeye, et al. (+38)
423 [GO] Eurosurveillance 2020―Jul―02 Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020 Fabiana Gámbaro, Sylvie Behillil, Artem Baidaliuk, Flora Donati, Mélanie Albert, Andreea Alexandru, et al. (+8)
424 [GO] Eurosurveillance 2020―Jun―25 SARS-CoV-2 does not replicate in embryonated hen’s eggs or in MDCK cell lines Ian G Barr, Cleve Rynehart, Paul Whitney, Julian Druce
425 [GO] Eurosurveillance 2020―Jun―18 Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020 Maximilian Muenchhoff, Helga Mairhofer, Hans Nitschko, Natascha Grzimek-Koschewa, Dieter Hoffmann, Annemarie Berger, et al. (+16)
426 [GO] Eurosurveillance 2020―Jun―18 Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 Elena Percivalle, Giuseppe Cambiè, Irene Cassaniti, Edoardo Vecchio Nepita, Roberta Maserati, Alessandro Ferrari, et al. (+9)
427 [GO] Eurosurveillance 2020―Jun―11 Measuring the effectiveness of an automated text messaging active surveillance system for COVID-19 in the south of Ireland, March to April 2020 Peter M Barrett, Niamh Bambury, Louise Kelly, Rosalind Condon, Janice Crompton, Anne Sheahan
428 [GO] Eurosurveillance 2020―Jun―11 Descriptive study of COVID-19 outbreak among passengers and crew on Diamond Princess cruise ship, Yokohama Port, Japan, 20 January to 9 February 2020 Takuya Yamagishi, Hajime Kamiya, Kensaku Kakimoto, Motoi Suzuki, Takaji Wakita
429 [GO] Eurosurveillance 2020―Jun―11 Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany Ute Rexroth, Osamah Hamouda, Johanna Hanefeld, Bettina Ruehe, Lothar H Wieler, Lars Schaade
430 [GO] Eurosurveillance 2020―Jun―11 Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications Saverio Caini, Federica Bellerba, Federica Corso, Angélica Díaz-Basabe, Gioacchino Natoli, John Paget, et al. (+8)
431 [GO] Eurosurveillance 2020―Jun―11 SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020 Nadia Oreshkova, Robert Jan Molenaar, Sandra Vreman, Frank Harders, Bas B Oude Munnink, Renate W Hakze-van der Honing, et al. (+13)
432 [GO] Eurosurveillance 2020―Jun―04 High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020 Kostas Danis, Laure Fonteneau, Scarlett Georges, Côme Daniau, Sibylle Bernard-Stoecklin, Lisa Domegan, et al. (+14)
433 [GO] Eurosurveillance 2020―Jun―04 Infection prevention guidelines and considerations for paediatric risk groups when reopening primary schools during COVID-19 pandemic, Norway, April 2020 Tone Bjordal Johansen, Elisabeth Astrup, Solveig Jore, Hege Nilssen, Bente Barton Dahlberg, Claus Klingenberg, et al. (+2)
434 [GO] Eurosurveillance 2020―Jun―04 Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020 Andreas Walker, Torsten Houwaart, Tobias Wienemann, Malte Kohns Vasconcelos, Daniel Strelow, Tina Senff, et al. (+11)
435 [GO] Eurosurveillance 2020―Jun―04 SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020 Alexandre Belot, Denise Antona, Sylvain Renolleau, Etienne Javouhey, Véronique Hentgen, François Angoulvant, et al. (+6)
436 [GO] Eurosurveillance 2020―May―28 No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020 Laura Heavey, Geraldine Casey, Ciara Kelly, David Kelly, Geraldine McDarby
437 [GO] Eurosurveillance 2020―May―28 Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020 Max Augustin, Philipp Schommers, Isabelle Suárez, Philipp Koehler, Henning Gruell, Florian Klein, et al. (+21)
438 [GO] Eurosurveillance 2020―May―28 Authors’ response: SARS-CoV-2 detection by real-time RT-PCR Victor M Corman, Christian Drosten
439 [GO] Eurosurveillance 2020―May―28 Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR Trestan Pillonel, Valentin Scherz, Katia Jaton, Gilbert Greub, Claire Bertelli
440 [GO] Eurosurveillance 2020―May―14 Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020 Paola Michelozzi, Francesca de’Donato, Matteo Scortichini, Manuela De Sario, Fiammetta Noccioli, Pasqualino Rossi, Marina Davoli
441 [GO] Eurosurveillance 2020―May―14 Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020 Helen I McDonald, Elise Tessier, Joanne M White, Matthew Woodruff, Charlotte Knowles, Chris Bates, et al. (+7)
442 [GO] Eurosurveillance 2020―May―14 Rapid reviews for rapid decision-making during the coronavirus disease (COVID-19) pandemic, Norway, 2020 Atle Fretheim, Kjetil G Brurberg, Frode Forland
443 [GO] Eurosurveillance 2020―May―07 Coronavirus disease (COVID-19) - impact on vaccine preventable diseases Daniel Hungerford, Nigel A Cunliffe
444 [GO] Eurosurveillance 2020―May―07 Projected early spread of COVID-19 in Africa through 1 June 2020 Carl AB Pearson, Cari Van Schalkwyk, Anna M Foss, Kathleen M O’Reilly, Juliet RC Pulliam
445 [GO] Eurosurveillance 2020―May―07 Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples Anne J Jääskeläinen, Eliisa Kekäläinen, Hannimari Kallio-Kokko, Laura Mannonen, Elisa Kortela, Olli Vapalahti, et al. (+2)
446 [GO] Eurosurveillance 2020―May―07 Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020 Mark Jit, Thibaut Jombart, Emily S Nightingale, Akira Endo, Sam Abbott, W John Edmunds
447 [GO] Eurosurveillance 2020―May―07 Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020 Silvia Garazzino, Carlotta Montagnani, Daniele Donà, Antonella Meini, Enrico Felici, Gianluca Vergine, et al. (+16)
448 [GO] Eurosurveillance 2020―Apr―30 Letter to the editor: Evidence on school closure and children’s social contact: useful for coronavirus disease (COVID-19)? Michele Poletti, Andrea Raballo
449 [GO] Eurosurveillance 2020―Apr―30 Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020 Tapiwa Ganyani, Cécile Kremer, Dongxuan Chen, Andrea Torneri, Christel Faes, Jacco Wallinga, Niel Hens
450 [GO] Eurosurveillance 2020―Apr―30 Temporal rise in the proportion of younger adults and older adolescents among coronavirus disease (COVID-19) cases following the introduction of physical distancing measures, Germany, March to April 2020 Edward Goldstein, Marc Lipsitch
451 [GO] Eurosurveillance 2020―Apr―30 Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 Filippo Lagi, Matteo Piccica, Lucia Graziani, Iacopo Vellere, Annarita Botta, Marta Tilli, et al. (+12)
452 [GO] Eurosurveillance 2020―Apr―23 Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 Marta Colaneri, Paolo Sacchi, Valentina Zuccaro, Simona Biscarini, Michele Sachs, Silvia Roda, et al. (+13)
453 [GO] Eurosurveillance 2020―Apr―23 Epidemiological characteristics of the first 53 laboratory-confirmed cases of COVID-19 epidemic in Hong Kong, 13 February 2020 Kin On Kwok, Valerie Wing Yu Wong, Wan In Wei, Samuel Yeung Shan Wong, Julian Wei-Tze Tang
454 [GO] Eurosurveillance 2020―Apr―23 Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 Ranawaka APM Perera, Chris KP Mok, Owen TY Tsang, Huibin Lv, Ronald LW Ko, Nicholas C Wu, et al. (+14)
455 [GO] Eurosurveillance 2020―Apr―23 Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020 Alma Tostmann, John Bradley, Teun Bousema, Wing-Kee Yiek, Minke Holwerda, Chantal Bleeker-Rovers, et al. (+6)
456 [GO] Eurosurveillance 2020―Apr―17 Coronavirus disease (COVID-19): a scoping review Meng Lv, Xufei Luo, Janne Estill, Yunlan Liu, Mengjuan Ren, Jianjian Wang, et al. (+15)
457 [GO] Eurosurveillance 2020―Apr―17 Potential lethal outbreak of coronavirus disease (COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020 Jean-François Etard, Philippe Vanhems, Laëtitia Atlani-Duault, René Ecochard
458 [GO] Eurosurveillance 2020―Apr―17 SARS-CoV2 infection and primary school closure Philippe Vanhems
459 [GO] Eurosurveillance 2020―Apr―09 Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020 Pierre-Yves Boëlle, Cécile Souty, Titouan Launay, Caroline Guerrisi, Clément Turbelin, Sylvie Behillil, et al. (+8)
460 [GO] Eurosurveillance 2020―Apr―09 A hundred days into the coronavirus disease (COVID-19) pandemic Ines Steffens
461 [GO] Eurosurveillance 2020―Apr―09 An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020 Anna S. Fomsgaard, Maiken Worsøe Rosenstierne
462 [GO] Eurosurveillance 2020―Apr―09 Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020 Alexander J Keeley, Cariad Evans, Hayley Colton, Michael Ankcorn, Alison Cope, Amy State, et al. (+4)
463 [GO] Eurosurveillance 2020―Apr―02 Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020 Frederik Verelst, Elise Kuylen, Philippe Beutels
464 [GO] Eurosurveillance 2020―Apr―02 Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020 Henrik Sjödin, Annelies Wilder-Smith, Sarah Osman, Zia Farooq, Joacim Rocklöv
465 [GO] Eurosurveillance 2020―Apr―02 Understanding coronavirus disease (COVID-19) risk perceptions among the public to enhance risk communication efforts: a practical approach for outbreaks, Finland, February 2020 Anna-Leena Lohiniva, Jussi Sane, Katja Sibenberg, Taneli Puumalainen, Mika Salminen
466 [GO] Eurosurveillance 2020―Apr―02 Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe Paola Stefanelli, Giovanni Faggioni, Alessandra Lo Presti, Stefano Fiore, Antonella Marchi, Eleonora Benedetti, et al. (+12)
467 [GO] Eurosurveillance 2020―Mar―26 Coronavirus disease (COVID-19) Community Testing Team in Scotland: A 14-day review, 6 to 20 February 2020 Kate Mark, Katie Steel, Janet Stevenson, Christine Evans, Duncan McCormick, Lorna Willocks, et al. (+6)
468 [GO] Eurosurveillance 2020―Mar―26 Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020 Giorgio Guzzetta, Piero Poletti, Marco Ajelli, Filippo Trentini, Valentina Marziano, Danilo Cereda, et al. (+8)
469 [GO] Eurosurveillance 2020―Mar―26 Updated rapid risk assessment from ECDC on coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK
470 [GO] Eurosurveillance 2020―Mar―26 Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020 Timothy W Russell, Joel Hellewell, Christopher I Jarvis, Kevin van Zandvoort, Sam Abbott, Ruwan Ratnayake, et al. (+4)
471 [GO] Eurosurveillance 2020―Mar―26 Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020 Chantal B Reusken, Anton Buiting, Chantal Bleeker-Rovers, Bram Diederen, Mariëtte Hooiveld, Ingrid Friesema, et al. (+15)
472 [GO] Eurosurveillance 2020―Mar―19 Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020 Emanuele Nicastri, Alessandra D’Abramo, Giovanni Faggioni, Riccardo De Santis, Andrea Mariano, Luciana Lepore, et al. (+27)
473 [GO] Eurosurveillance 2020―Mar―19 Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 Anu Haveri, Teemu Smura, Suvi Kuivanen, Pamela Österlund, Jussi Hepojoki, Niina Ikonen, et al. (+17)
474 [GO] Eurosurveillance 2020―Mar―17 Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19) Kristin Tolksdorf, Silke Buda, Ekkehard Schuler, Lothar H Wieler, Walter Haas
475 [GO] Eurosurveillance 2020―Mar―17 Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020 Pete Kinross, Carl Suetens, Joana Gomes Dias, Leonidas Alexakis, Ariana Wijermans, Edoardo Colzani, Dominique L. Monnet
476 [GO] Eurosurveillance 2020―Mar―12 Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 Kenji Mizumoto, Katsushi Kagaya, Alexander Zarebski, Gerardo Chowell
477 [GO] Eurosurveillance 2020―Mar―12 Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020 Yuanyuan Xing, Pingzheng Mo, Yu Xiao, Oiu Zhao, Yongxi Zhang, Fan Wang
478 [GO] Eurosurveillance 2020―Mar―12 Retrospective analysis of the possibility of predicting the COVID-19 outbreak from Internet searches and social media data, China, 2020 Cuilian Li, Li Jia Chen, Xueyu Chen, Mingzhi Zhang, Chi Pui Pang, Haoyu Chen
479 [GO] Eurosurveillance 2020―Mar―12 Updated rapid risk assessment from ECDC on the novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK
480 [GO] Eurosurveillance 2020―Mar―05 Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020 Helen C Johnson, Céline M Gossner, Edoardo Colzani, John Kinsman, Leonidas Alexakis, Julien Beauté, et al. (+4)
481 [GO] Eurosurveillance 2020―Mar―05 First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020 Gianfranco Spiteri, James Fielding, Michaela Diercke, Christine Campese, Vincent Enouf, Alexandre Gaymard, et al. (+45)
482 [GO] Eurosurveillance 2020―Mar―05 Updated rapid risk assessment from ECDC on the outbreak of COVID-19: increased transmission globally
483 [GO] Eurosurveillance 2020―Mar―05 Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020 Regina Konrad, Ute Eberle, Alexandra Dangel, Bianca Treis, Anja Berger, Katja Bengs, et al. (+4)
484 [GO] Eurosurveillance 2020―Mar―05 Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system Susanne Pfefferle, Svenja Reucher, Dominic Nörz, Marc Lütgehetmann
485 [GO] Eurosurveillance 2020―Feb―27 Latest assessment on COVID-19 from the European Centre for Disease Prevention and Control (ECDC)
486 [GO] Eurosurveillance 2020―Feb―27 Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020 Pilailuk Okada, Rome Buathong, Siripaporn Phuygun, Thanutsapa Thanadachakul, Sittiporn Parnmen, Warawan Wongboot, et al. (+10)
487 [GO] Eurosurveillance 2020―Feb―27 Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020 Licia Bordi, Emanuele Nicastri, Laura Scorzolini, Antonino Di Caro, Maria Rosaria Capobianchi, Concetta Castilletti, Eleonora Lalle
488 [GO] Eurosurveillance 2020―Feb―27 Authors’ response: Plenty of coronaviruses but no SARS-CoV-2 Chantal B Reusken, Bart Haagmans, Adam Meijer, Victor M Corman, Anna Papa, Remi Charrel, et al. (+2)
489 [GO] Eurosurveillance 2020―Feb―27 Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2 Philippe Colson, Bernard La Scola, Vera Esteves-Vieira, Laetitia Ninove, Christine Zandotti, Marie-Thérèse Jimeno, et al. (+8)
490 [GO] Eurosurveillance 2020―Feb―13 Latest updates on COVID-19 from the European Centre for Disease Prevention and Control
491 [GO] Eurosurveillance 2020―Feb―13 First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020 Sibylle Bernard Stoecklin, Patrick Rolland, Yassoungo Silue, Alexandra Mailles, Christine Campese, Anne Simondon, et al. (+17)
492 [GO] Eurosurveillance 2020―Feb―12 Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020 Chantal B.E.M. Reusken, Eeva K. Broberg, Bart Haagmans, Adam Meijer, Victor M. Corman, Anna Papa, et al. (+4)
493 [GO] Eurosurveillance 2020―Feb―12 Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak Benjamin J Cowling, Gabriel M Leung
494 [GO] Eurosurveillance 2020―Feb―06 Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV) Billy J Quilty, Sam Clifford, Stefan Flasche, Rosalind M Eggo
495 [GO] Eurosurveillance 2020―Feb―06 Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020 Jantien A Backer, Don Klinkenberg, Jacco Wallinga
496 [GO] Eurosurveillance 2020―Feb―01 Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern
497 [GO] Eurosurveillance 2020―Jan―30 Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 Julien Riou, Christian L. Althaus
498 [GO] Eurosurveillance 2020―Jan―30 Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020 Giulia Pullano, Francesco Pinotti, Eugenio Valdano, Pierre-Yves Boëlle, Chiara Poletto, Vittoria Colizza
499 [GO] Eurosurveillance 2020―Jan―23 Note from the editors: novel coronavirus (2019-nCoV)
500 [GO] Eurosurveillance 2020―Jan―23 Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Victor M Corman, Olfert Landt, Marco Kaiser, Richard Molenkamp, Adam Meijer, Daniel KW Chu, et al. (+18)
501 [GO] Eurosurveillance 2020―Jan―23 Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020 Peng Wu, Xinxin Hao, Eric H Y Lau, Jessica Y Wong, Kathy S M Leung, Joseph T Wu, et al. (+2)

501 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec